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ABSTRACT 
The effects of facilitatory drugs (neostigmine, edrophonium, amben-
~: , ' 
onium and methoxyambenonium) at the skeletal neuromuscular junction 
have been studied using intracellular microelectrodes in the isolated 
tenuissimus muscle of the cat. These drugs produced small changes in 
miniature end-plate potential (m. e. p. p.) frequency. The m. e. p. p. s were 
prolonged by neostigmine, ambenonium and methoxyambenonium, but not 
by edrophonium. High concentrations of neostigmine and edrophonium 
depressed the m. e. p. p. amplitude concurrent with a decrease in the 
resting mc.i..n.b!'ane potential. High c-0nccntr:::1.tions cf ::>cmb•=""'0l"li 11 rn ~ni4 
methoxyambenonium depressed the m. e. p. p. amplitude with no change in 
the resting membrane potential. 
The amplitude of (+)-tubocurarine end-plate potentials (e. p. p. s) was 
increased without change in time-course by all four drugs at a conc~ntra: 
tion which had no effect on m. e. p. p. s. The half-decay of (+)-tubocurar.i.ne 
e. p. p. s was prolonged at the same concentration which prolonged the 
m. e. p. p. s. On the other hand the facilitatory drugs produced nearly 
equivalent changes in (+)-tubocurarine e. p. p. s and iontophoretic acetyl-
choline-potentials. The drugs did not increase the quanta! release in 
.. ma aa 
-
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deficient calcium and high magnesium ion concentrations. Benzoquinon-
ium e. p. p. s were not affected by the facilitatory drugs. These results 
are discussed in conjunction with the current theories of neuromuscular 
pharmacology. 
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INTRODUCTION 
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~ --------~-------------------~--------------------':"""""'----. 
9 
~~tomy of the neuromuscular junction 
Motor nerve axons originate in the ventral root of the spinal. cord and 
extend to the periphery where they make synaptic contact with skeletal 
muscle fibers (Sherrington, 1925 and Tiegs, 1932). The motor nerve 
axon is a large diameter neuron surrounded by layers of myelin, produced 
by an associated Schwann ·cell {Geren, 1954 and Robertson, 1955). Because 
a single motor nerve branches in the nerve trunk (Adrian, 1925) and near 
the muscle fiber, it can innervate between 100 and 200 muscle fibers 
(Fulton, 1926 and Clark, 1931). The nerve, together with its muscle fibers~. 
is called a 'motor unit' (Sherrington, 1925). The muscle fibers of a motor 
unit are arranged in a longitudinal or chain-like manner (Adrian, 1925 and 
Cooper, 1929). 
Until the development of electronmicroscopy, there was much debate 
concerning the anatomy of the neuromuscular junction. The nerve loses 
its myelin sheath at the terminal. The nerve terminal, which has a 
diameter of 2 to 3 microns lies in a synaptic trough on the surface of the 
! 
\ 
muscle fiber (Anderson-Cede.rgren, 1959 and DeHarven and Coers, 1959). 
A Schwann cell always encloses the surface of the nerve terminal away 
from the synapse (Birks, :fluxley and Katz, 1960). The axoplasm does not 
make cont;l.ct with the sarcoplasm (Reger, 1954) but is separated by a 
five-layered membrane, the synaptolemma. The synaptolemma is com-
10 
posed of neurilemma and sarcolemma which combine in the area of the 
neuromuscular junction (Robertson, 1954; Couteaux, 1958 and Reger, 1958). 
The nerve terminal and muscle end-plate (e. p.) are separated by a primary 
synaptic cleft which is 200 Angstrom units wide {Palay, 1958). In the 
region of the nerve terminal the muscle membrane is thrown into a series 
of junctional folds- -secondary synaptic clefts (Pa.lade and Palay, 1954; 
Reger, 1954 and -Robertson, 1954). They are approximately one micron 
long and one-tenth micron wide, being narrower toward the axonal surface 
(Robertson, 1956). The junctional folds probably are the "subneural 
apparatus" which is so prominent "in Couteaux's (1955) light microscope 
::=ections. 
The axoplasm which doe$ not dip into the junctional folds is distin-
guished by the presence of mitochondria {Robertson, 1956). Another distin-
guishing feature of the axoplasm is the occurrence of "synaptic vesicles" 
(300 to 500 Angstrom units in diameter) which are concentrated near dense 
presynaptic membra11e areas directly opposite a junctional fold (Birks, 
Huxley and Katz, 1960 and Hubbard and Kwanbunbumpen, 1968). 
Birks (1966) made an unusual observation. By using acrolein as a 
fixing agent, rather than osmium tetraoxjde, a tubular system appeared 
in tt;ie nerve terminal a.xoplasm. Thus vesicles may be a fixation artifact. 
11 
~~_!:_ology of the neuromuscular junction 
In a quiescent nerve-muscle preparation, small depolarizations of the 
membrane occur at the end-plate region of the muscle fiber. These 
miniature end-plate potentials (m. e. p. p. s)-initially called "end-plate 
noise" (Fatt and Katz, 1950)-have been recorded in several species, 
including frog (Fatt and Katz, 1950), rat (Liley, 1956a). guinea pig (Brooks, 
1956b), cat (Boyd and Martin, 1956a) and human (Elmqvist, Johns and 
Thesleff, 1960). Each rh. e. p. p. is due to the spontaneous release of a 
single quantum, which contains many molecules of transmitter (Fatt and 
Katz, 1952; Liley, 1956a and Boyd and Martin, 1956a}. These quanta are 
r tlta>:>c:d froiu the nerve tern1inal (Fati. and Katz, 18 52), c..1-::hvi..i.~1:.. they i110.y 
originate from other structures (Birks, Katz and Miledi, 1960). 
Upon activation of the motor nerve an action potential invades the motor 
nerve terminal, where it initiates the release of transmitter (Hubbard and 
Schmidt, 1962 and Katz and Miledi, 1965c). In the unmyelinated terminal 
the action potential has a slow conduction velocity and long after-potentials. 
i 
These characteristics are typical of an unmyelinated C-fiber (\Verner, 1960a; · 
Hubbard and Schmidt, 1961; Blaber and Bowman, 1963b; Katz and Miledi, 1965 
When transmitter release is measured in the presence of deficient 
calicum ions or excess magnesium ions, the end-plate depolarization 
(end-plate potential- -e. p. p. ) becomes quite small. If the calcium ion con-
centration is sufficiently low, the e. p. p. a.m·plitude fluctuates considerably 
with many of the e. p. p. s having exactly the same amplitude and time 
·course as m. e. p. p. s. The smallest e. p. p. s which occur are essentially 
m. e. p. p. s and the larger e. p. p. s are multiple m. e. p. p. s (Fatt and Katz, 
1952}. The e. p. p. amplitude in deficient calcium follows a Poisson 
distribution indicating an independent release of quanta from the activated 
terminal (del Castillo and Katz, 1954b; Martin, 1955; Boyd and Martin; 
1956b; and Liley, 1956b). On the basis of these results Liley (1956c) and 
Katz (1962) concluded that a nerve stimulus merely increases the rate 
of spontaneous release of transmitter. 
On first analysis there appeared to be a correlation between the 
amplitude of the nerve terminal depolarization and the release of trans-
mitt er. This relationship was arrived at by correlating the calculated 
depolarization induced by various extracellular potassium ion concentra-
tions with the changes of m. e. p. p. frequency induced by the corresponding 
' I._ 
potassium ion concentration. Liley (1956c) stated that a 15 millivolt (mV) 
depolarization produces a ten-fold increase in m. e. p. p. frequency. 
According to his hypothesis, the nerve terminal action potential increases 
the release of transmitter by increasing the m. e. p. p. frequency in a 
logarithmic fashion. No other steps were considered necessary for 
release. On the basis of Liley' s results it was possible to account for 
13 
all the quanta released by an action potential. Due to the logarithmic na.:. ·· 
ture of the release, most of the release would occur at the peak of the 
action potential, when the m. e. p. p. frequency would be extremely high 
(Eccles and Liley .. 1959). This theory also accounted for the observation 
that depolarization of the nerve terminal decreased the amplitude of the 
e. p. p. (Hubbard and w·illis, 1962b and 1968 and Vladimirova, 1964) and 
hyperpolarization of the terminal increased the amplitude of the e. p. p. 
(del Castillo and Katz, 1954b: Hubbard and Willis, 1962a and 1962c and 
Vladimirova. 1964). On the basis of Lloyd's results {1950) in the spinal 
cord, Eccles and Liley (1959) concluded that depolarization decreased the 
amplitude of the terminal spike and thereby, decreased transmitter release; 
while hy-perpolarization increased the amplitude of the terminal spike and 
increased transmHter release. 
Although this simple theory was quite attractive, data began to 
accumulate indicating that transmitter release involves much more than 
just depolarization of the nerve terminal (Hubbard and Schmidt, 1963; 
Katz and MilecU, l965d, 1965e and 1967a and Hubbard, Jones and Landau, 
1967). It has been shown that calcium ions are eosential for neurornuscular 
transmission (F:-. ~, 1936; Cowan, 1940; Kuffler, 1944; del Castillo aud 
Stark, 1952; Fatt and Katz, 1952; del Castillo and Katz, 1954b; Boyd and 
Martin, 1956b and Liley, 1956c) and for spontaneous release of transmitter 
14 
(Boyd and Martin, 19 56a; Elmqvist and Feldman, 19 65a; Hubbard, 19 61 and 
Hubbard,Jones and Landau, 1968a). Lowering the calcium ion concentration 
decreases transmitter release with no effect on the nerve terminal action 
potential (Katz and Miledi, 1965d, 1965e and 1967a). Thus Liley's theory 
had to be modified to include a calcium step. The exact mechanism by 
which calcium ions affect release of transmitter is not known. Del 
Castillo and Katz (1954a and 1954c) hypothesized that calcium ,acts with an 
external component of the nerve terminal (X). The complex (CaX) moves 
intraterminally during the terminal action potential and causes the release 
of a quantum of transmitter (Gage, 1967; Hubbard, Jones and Landau, 1968a; 
RahamimofI, 1968 and Katz and Miledi, 1968). Raharn.imuff (1963) and D0dg~ 
and Rahamimoff (1967) have further hypothesized that four calcium ions are 
necessary to release one quantum of transmitter. This action of calcium is 
quite rapid and can be shown to occur even during the falling phase of the 
terminal action potential (Katz and Miledi, 1967a and 1967c). Calcium can 
be replaced in this 9.CtTun by strontium or barium ions (Elmqvist and 
Feldman, 1965a and Miledi, 1966). 
All the actions of calcium ions which have been previously described at 
the neuromuscular junction are antagonized by magnesium ions. The mag-
nesium ions decrease release of transmitter by competitively inhibiting 
the action of calcium ions (Del Castillo and Engback, 1954; Del Castillo and 
15 
Katz, 1954a; Huiier and Kostial, 1954; Liley, 1956c; Jenkinson, 1957; 
Hubbard, 1961; Hubbard and Willis,1962c and 1968; Hubbard and Schmidt, 
1963 and Hubbard,, Jones and Landau, 1968a). Magnesium ions may augment 
release, except their activity in this regard is much less than the activity 
of calcium ions ' (Hubbard, Jones and Landau, 1968a). 
Some workers also involve sodium ions, directly, in the release of 
transmitter. rather than through any effects on the sodium conductance of 
the terminal action potential. Changing the sodium ion concentration has 
no effect on release in a normal ionic solution {Del Castillo and Katz, 1955b 
and Co1omo and Rahamimoff, 1968). When the muscle is immersed in 
tetrodotoxin, which blocks sodium conductance changes in nerve or muscle, 
release is normal (Elmqvist and Feldman, 1965c and Katz and Milcdi, J967h) 
But in a deficient calcium ion concentration, . a decrease in the sodium 
ion concentration '\Vill increase m. e. p. p. frequency, augment the e. p. p. 
and increase the quantal content of the e. p. p. (Gage and Quastel, 1965b and 
1966; Kelly, 1965; Rahamimoff and Colomo, 1967 and Colomo and Rahami-
moff1 1968). It has been hypothesized that sodium ions compete extrater-
minally with the calcium ions for the receptor (X). 
Digoxin and ouabain inhibit the sodium-potassium pump by inhibiting 
ATPase. They cause an inc~e::e :ease =nsmitter whlch must J . 
~-------------------------------------------------------------------------~ 
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be due to a build up of sodium ions intraterminally (Birks, 1962 and 1963 
and Elmqvist s.nd Feldman,1965b). Thus it has been further hypothesized 
that sodium ions compete with calcium ions intraterminally, as well as 
extraterrninally (Birks. and Cohen, 1965, 1968a and 1968b). 
Gage and Quastel (1965a) and Parsons, Hofmann and Feigen (1965) have 
involved potassium ions in the release of transmitter; although it is quite 
difficult to distinguish between indirect effects on the nerve terminal 
membrane potential and direct effects on transmitter release. 
Chloride ions are not involved in the release of transmitter (Elm.qvist 
and Feldman. 1966). 
Hypoxia, stretch, increased osmotic pressure and increased 
temperature all increase m. e. p. p. frequency and all, except hypoxia., 
·increase the release of transmitter. Hypoxia decreases release, and prob-
_ably does so by blocking the sodium-potassium pump, thereby depolarizing 
the terminal membrane (Hubbard and Loyning, 1966). Stretch, increased 
osmotic pressure and increased temperature act by different mechanisms 
to increase release (Fatt and Katz, 1952; Boyd and Martin, 1956a and 
1956b; Furshspan, 1956; Hutter and Trautwein, 1956; Liley, 1956a; 
Takeuchi, 1958b and Hubbard, Jones and Landau, 1968b). 
17 
Since the ·work of Dale and his co-workers, it is generally accepted th2.t 
acetylcholine (ACh) is the transmitter at the neuromuscular junction. 
ACh has been isolated from a neuromuscular preparation following 
indirect stirnulationJDale, Feldberg and Vogt, 19~i6) and this ACh arises 
from the nerve (Straughan, 1960 and Krnjevic and Mitchell, 1961). 
Inj ected P.Ch mimics the effects of indirect stimulation (Brown, Dale 
and Feldberg, 1936 and Brown, 1937). Also, the synthesizing and 
degradating enzymes for A Ch are present (Marneymd Nachmansohn, 19311 
and Nachmansohn and Machado, 1943}. 
ACh is synthesized from choline and acetyl co-enzyme A in the 
pre.scEc.e of the enzyine, choline acetyl transfercise-ChAc (Nachmansohn 
and Machado; 1913 and Korkes, Del Campillo, Korey, Stern, Nachmansolm 
and Ochoa, 1952). The site of synthesis is not established. rt has been 
suggested that synthesis may take place in the terminal axoplasm 
(V./hitt8ker, Michaelson and Kirkland, 1964 and Michaelson, 1967), 
mitochondria (Bodian, 1942 and Hebb and Smallnian, 1956) or synaptic 
vesicles (Hebb and Whittak2r, 19~18; Vvhittakcr, 1959 and DeRobertis, 
Arnaiz, S2.lganiccff, Iraldi and Zieher, 1963). The ACh is stored in a 
bound form (Elliot and Henderson, 1951 and Brodkin and Elliot, 1953). 
Many workers feel that the vesicles in the electronrnicrograph represent 
the 'bour1d for'm of ACh (DeRobertis and Bennett, 1955; Del Castillo and 
• 
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Katz, 1955b; Macintosh, 1959 and Hubbard and Kwanbunbumpen, · 1968). 
The transmitter whie:h is present in the nerve terminal can be 
divided into two functionally, distinct stores- -"the available store" which 
is readily releaseable, and the "unavailable store" which is not readily 
releaseable. An indirect stimulus depletes the available store. This 
store is rapidly refilled {Gage and. Hubbard, 1965) from the uriavailable 
store. The unavailable store is comparatively, slowly filled; as it depends 
on synthesis for its transmitter (Perry, 1953; Birks and Macintosh, 1957 
and 1961 and Thies, 1960). The available store may be represented by the 
vesicles which are located near the region of the presynaptic membrane, 
while the unavailable store may be the vesicles which are further from the 
membrane (Hubbard and Kwanbunbumpen, 1968). Elmqvist and Quastel 
(1965} and Elmqvist (1965) estimate the total releaseable store to be 
around 200, 000 quanta. 
The mechanism whereby the vesicle extrudes its contents from the 
nerve terminal is unknown, but probably involves contact of the vesicle 
with the presynaptic membrane. In this way the vesicle ejects the 
transmitter directly into the synaptic gap (Katz, 1962; Bass and Moor~, 
1966 and Hubbard, Jones and Landau, 1967). Hubbard and Kwanbunbumpen 
(1968) were able to observe a few vesicles which were fused with the 
: . 
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terminal membrane. Once the transmitter is released, it rapidly diffuses 
throughout the synaptic gap (Eccles and Jaeger, 1958) and comes into 
contact with at least two types of receptors -- acetylcholinesterase and 
the junctional receptor. The neuromuscular junction contains a high 
concentration of the degrading enzyme for ACh, acetylcholinesterase 
(Feng and Ting, 1938; Marney and Nachmansohn, 1938; Augustinsson 
and Nachmansohn, 1949; Koelle and Friedenwald, 1949 and Koe11e, 
1950 and 1951). Most of the acetylcholinesterase occurs in the post-
synaptic regions; although it is present at four sites in the junction: 
1) the plasma membrane of muscle covering the junctional folds, 
2} the prlrnal1 y and secondary synaptic cl~fts, 3) the plasma me.mhra;ic 
covering the terminal '· and 4) the vesicles of the terminal (Barrnett, 
1962 and 1966 and Miledi, 1964). The acetylcholinesterase catalyzes the 
hydrolysis of ACh to choline and acetate, (Matthes. 1930 and Stedman, 
Stedman and Easson, 1932). thereby reducing the activity of the trans-
mitter at the cholinergic receptor by a factor of 1000 (Bacq and Brown, 
H}37). 
The ACh also acts at the nicotinic, cholinergic receptors {Langley, 
190'/ and Bacq and Brown, 1937) which are located in the e. p. region of 
the muscle fiber {Nastuk, 1953a; Del Castillo and Katz, 1955a and Ki:i.tz 
and Miledi, 196la). As the muscle membrane is impermeable to ACh 
20. 
(Del Castillo and Katz, 19~Sa), the receptors must be locate.cl on the 
external surface of the muscle membrane. ' When ACh· activates ~ receptor; 
r . " 
the membrane resistance .d.ecreases (Katz; 1942 ·and Takeuchi.and Takeuchi, 
-1960a), -dne to t..lle-simultaneous.-increase in-.permeability to both·sodiurn 
and potassium ions~ but not to chloride ions (Del Castillo and KatzJ 1954e; 
Takeuchi and Takeuchi, 1960b and Takeuchi, 1963). ACh does not carry 
the current (Nastuk, 1953b and Del Castillo and Katz, 1955a). Due to this 
flo\v of sodium and potassium ions, the e. p. membrane potential 
approaches the e~uilibrium potential of the muscle fiber - - 10 to 20 
millivolts, negative (Del Castillo and Katz, 195~e and Takeuchi and 
Takeuchi., 1959). ·when the membrane potential reaches a c.ri.tieal depo-
larization- -threshold- -sufficient current flow is e.stablisb~o to activate 
· the all or none processes of the muscle fiber (Ecclts, Katz an.ti Kufflef", 
1941; Kuffler, 1942 and Fatt and Katz, 1951). The action of the tra.nsm.itter 
is very sho:ti and irr1pulsive (Eccles, Katz and Kuffler, 1941) and the level 
of depolarization is determ1ned by the concentration of transtnilter in the 
area of the choli11ergic receptor (Eccles and .Jaeger, 1958). When the 
transmitter release is complete, the concentration of transmitfor falls, 
rapidly, as it is inactivated by acetylcholinesterase (Marney and Nae htnan-
sohn, 1938) or diffuses from the region of the e. p. (Ogston, 1955 and 
Eccles and Jaeger, 1958). Then the e. p. p. passively decays in a logarithmic 
------------·;··--------------------------
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fashion, until it returns to the resting membrane potential (Eccles, Katz 
and Kuffler, 1941; Katz, 1942 and F'att and Katz, 1951). Although the 
e. p. is cbemically excitable, it is probably electrically inexcitable 
_ . _ (Werrnan,_ 1960). 
Nor-mally, the e. p. p. is quite large and always initiates a muscle 
action potential (KuffJ.er, 1942). In order to record a pure e. p. p., it 
i.s necessary to block the initiation of the muscle action potential. This · 
can be accomplished by stimulating the nerve during a refractory state 
or adrr1.·inistering (+)-tubocurarine (Gopfert and Schaefer, 1938 and Eccles 
amt O'Connor, 1939 and 1941 ). In this manner it is possible to study 
nearomuscular transmission by studying changes in the extracellular 
or intracellular e. p. p. (Fatt and Katz, 1951; Nastuk, 1953b and Del 
Castillo and Katz, 1956). 
The e. p. p. follows the stimulus after a period of latency - - the 
synaptic delay. The synaptic delay is not due to diffusion of transmitter 
across the junction or to activation of the receptor substance. It must 
be due to a delay in the release of transmitter, probably involving the 
electro·-secretory coupling process (Katz and Miledi, 1965a, 1965b, 
1965d, 1967a, 1967c and.1967d). 
22 
Stimulation of the nerve sets up conditions in the motor nerve terminal 
such that after the stimulus the probability of release is greater than in 
the contro1 state (Feng, 1940; Eccles, Katz and Kuffler, 1941 and 1942; 
Hutter, 1952; Liley and North, 1953; Lundberg and Quilisch, 1953a and 
1953b; Brooks ,1956a and 1956b; Liley, 1956a and 1956b and Hubbard, 1959 
and 1963). This is referred to as post-activation potentiation (p.a. p.) or 
post ... tetanic potentiation (p. t. p.) and occurs independently of release from 
the conditioning impulse (Del Castillo and Katz, 1954c and Hubbard, 1963). 
The quanta of transmitter (m) which a nerve impulse releases depends on 
the number of quanta available for release (n) and the probability that a 
single quahta will be released (p). 
m = np (Martin, 1965) 
During the period of post-activation potentiation· each quantum has a 
greater probability of being released (Mallart and Martin,19£7 and 1968) 
and under appropiate conditions will result in an increase in the quanta 
released and a larger e. p. p. (Lundberg and Quilisch, 1953a and 1953b; 
Del Castillo and Katz, 1954c and Liley, 1956b). 
There are several mechanisms by which this change of m can occur. 
The nerve terminal action potential has a positive (or hyperpolarizing) 
after-potentia1 (Hubbard and Schmidt, 1961 and 1963) due to a prolonged 
increase of potassium conductance (Gage and Hubbard, 1964 and 1966a). 
23 
According to Liley' s theory. this hyperpolc:rization would increase the 
amplitude of the succeeding terminal spikes and increase the release of 
transmitter (Eccles and Liley. 1959). But there is not complete corre-
lation between th~_tim~ course of effects of hyperpolarization and the 
increased release (Hubbard. 1959 and 1963; Hubbard and Willis, 1962a 
and 1962b and Hubbard and Schmidt. 1962 and 1963). Hubbard (1963) 
observed two phases of facilitation, each due to increased release of 
transmitter; and hypothesized that the early phase was due to mobilization 
of transmitter to the release sites, while the secondary phase was the 
result of a larger presynaptic spike from hyperpolarization. Katz and Mil-
edi (1967b) observed that facilitation did not depend on a change in the 
terminal action potential. Gage and Hubbard {l966b) concluded that 
post-tetanic potentiation was :1ot due to mobilization in the terminal. 
They also eliminated several other possibilities, including presynaptic 
swelling. increased intracellular sodium and decreased intracellular 
potassium. 
Changing the extracellula'r calcium ion concentration directly affects 
the _r:Glcase of transmitter, as described previously. Due to this pro-
nounced effect of calcium ion on release. it was suggested that residual 
calcium intraterminally may account for facilitation {Katz and Miledi, 
,' 
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1965e and Gage and Hubbard, 1966b). Katz and Miledi (1967a and 1967c) 
observed that the process of transmitter release continues to operate and 
even increases during the falling phase of the- terminal action potential. 
Calcium utilization occurs during the depolarization of the nerve terminal 
(Katz and Miledi, 1967d) and facilitation is increased only when calcium 
ions are present during the conditioning stimulus (Katz and Miledi, 1968). 
Rahamimoff (1968) suggested that four calcium ions act at a receptor to 
release one quanta of transmitter. Facilitation would be expected to occur 
if one or more calcium ions remain attached to the receptor until the 
next impulse arrives. 
Facilitation of the e. p. p. does not occur in all situations involving 
more than one indirect stimulus. When the muscle is blocked by 
(+)-tubocurarine, the second e. p. p. of mammalian preparations-arid 
subsequent e. p. p. s of amphibian preparations become depressed (Eccles, 
Katz and Kuffler, 1941 and 1942 and Lundberg and Quilisch, 1953a). This 
depression has been shown to be due to a decreased quanta! content of the 
test e. p. p. {Hutter, 1952; Perry, 1953; Del Castillo and Katz, 1954c; 
Takeuchi, 1958a; Thies, 1960 and 1965; Brooks and Thies, 1962 and 
Elrnqvist and Quastel, 1965). Thesleff has shown some evidence for a 
postsynaptic desensitizing action from accumulated ACh, as a result of 
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the tetanus (Axelsson and Thesleff, 1958 and Thesleff, 1959); but these 
results have been directly countered by others who show no evidence for 
a desensitizing action during a tetanus (Otsuka and Endo, 1960a; Lilleheil 
and Naess, 1961 and Otsuka, Endo and Nonomura, 1962). It is possible 
that a tetanic depression may be due to a propagation failure in the fine 
nerve terminals (Krnjevic and Miledi, 1958 and 1959); but this type of 
failure occurs only at high frequencies of stimulation and would be quite 
obvious with unicellular recording techniques, if it did occur. 
Evidence indicates that the decreased quantal content is due to a 
depletion of the available stores of ACh (Perry, 1953 and Hubbard and 
Kwanbunbumpen, 1968), even though there is an increased probability 
of release during the depression (Elmqvist and Quastel, 1965 and Mallart 
and Martin, 1968). The results from the deficient calcium experiments 
are different as they do not involve a depletion of the available store. 
Thus they show only the increased probability of release (Mallart and 
Martin, 1868). 
In the in vivo experiments the muscle contracts supramaximally when 
tetanically stimulated. The tetanic contraction reaches a plateau and be-
gins to relax from the supramaximal contraction. Upon cessation of the 
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tetanus, the twitch again becomes supramaximal-- p. t. p. of the twitch 
(Guttman, Horton and Wilber, 1937; Rosenhlueth and Morison. 1937; 
Feng. Lee, Meng and Wang. 1938 and Von Euler and Swank. 1940). 
_The m1usual _aspect of this observation is the fact that the muscle can 
contract greater than maximally. This has been shown to occur upon 
direct stimulation of denervated or curarized muscles with no change 
in the gross muscle action potential (Brown and Von Euler. 1938 and 
Von Euler and Swank. 1940). Thus the supramaximal contraction involves 
the active state of the muscle fibers and not the neuromuscular junction 
(Hill, 1949; Macpherson and Wilkie, 1954; Ritchie and "Wilkie, 1955 and 
Close and Hoh, 1968). In the frog part of the p. t. p. of the twitch can be 
explained by recruitment of quiescent muscle fibers (Grumback and Wilber. 
1940), but this is probably due to the low safety factor of transmission in 
some muscle fibers of the frog (Wakabayashi and Iwasaki, 1962). This 
would not be expected to occur in mammals which have a high safety factor 
of neuromuscular transmission (Paton and Waud. 1967). 
The tctanic depression is due to a decreased release of ACh. as a 
result of depletion. Thus many of the e. p. p. s are below threshold and 
the gross muscle twitch becomes smaller (Dale. Feldbert and Vogt, 
1936; Brown and Von Euler. 1938 and Li and Ting, 1941). 
!""'.· 
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When the motor nerve to a skeletal muscle is cut. the muscle becomes 
inactive for a period of 12 to 15 days {Hines. Thomson and Lazere, 1942). 
The distal nerve degenerates and loses its ability to initiate musde activity.· 
At the same time there is a decrease in the ACh and ChAc activities 
(Feldberg, 1943; Bannister and Scrase. 1950 and Berry and Rossiter, 1958). 
The nerve completely degenerates leaving only the Schwann cells (Birks. 
Katz and Miledi, 1960). The m. e. p. p. s which had completely disappeared 
shortly after sectioning the nerve. reappear after several days and must 
originate from a site other than the nerve - - possibly the Schwann cell 
(Birks, Katz and Miledi, 1960). During degeneration the whole muscle 
fiber becomes sensitive to ACh (Luco and Eyzaguirre. 1955; Axelsson 
and Thesleff, 1959; Miledi, 1959 and 1960a; Frank. 1959; Jenkinson. 1960 
and Katz and Miledi, l96lb) and there is a decrease in the acetylcholin-
esterase concentration around the original e. p. (Snell and Mcintyre, 1955 
and Frank. 1959). 
The distal stump of the regenerating neuron contains high concentration ; 
of acetylcholinesterase and choline acetyl transferase, indicating that 
these enzymes are produced by the nerve cell body (Sawyer, 1946; Hebb 
and Waites, 1956 and Hebb and Silver, 1961). The regenerating stump 
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approaches the muscle fiber and induces the formation of an e. p. Also, 
there is a sensitivity decrease to ACh at the non-e. p. regions of the 
t 
muscle ·and an increase in the acetylcholinesterase concentration at the 
e...p. .It has been concluded that this effect of the nerve on the .muscle is 
due to a neural factor (probably not ACh) which is released and can induce 
profound changes in the muscle fiber (Buller, Eccles and Eccles, 1960a 
and 1960b and Miledi, 1960b and 1962). 
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Drug-induced facilitation of neuromuscular transmission 
Facilitation is defined as an increase in the twitch tension of an 
indirectly stimulated skeletal muscle or antagonism of (+)-tubocurarine 
paralysis. Drugs which produce facilitation are termed 'facilitatory 
drugs'. The majority of these drugs have been shown to produce some 
inhibition of cholinesterase. 
As early as 1900, it was shown that physostigmine is capable of antag-
onizing neuromuscular paralysis induced by curare and this observation 
has since been reported many times (Pal, 1900; Rothberger, 1901; 
Rosenblueth, Lindsley and Morison, 1936 and Koppanyi and Vivino, 1944). 
Also, physostigmine can facilitate the maximal indirect twitch of the cat 
gastrocnemius muscle. It has no effect on nerve conduction and is 
ineffective when the muscle is stimulated directly in a curarized or 
denervated preparation. The facilitation is associated with repetitive 
action potentials in the muscle fibers, which occur at intervals near the 
absolute refractory period of the muscle fiber. This repetition acts 
as a tetanus and induces a tetanic-like contraction of the muscle fiber, 
resulting in facilitation of the muscle contraction (Brown, Dale and 
Feldberg, 1936 and Brown, 1937). ACh, administered close-arterially, 
also elicits a brief, asynchronous tetanus. Thus the drug-induced 
repetitive firing is probably due to maintenance of transmitter 
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at the muscle e. p. As physostigmine is well known for its ability to 
prolong the action of ACh by inhibition of cholinesterase and as it also 
' . 
slightly increases the ACh contraction(Englehart and Loewi, 1930; Matthes, 
1930 and Bacq and Brown, 1937), it seemed reasonable for the early 
workers to conclude that physostigmine maintains transmitter levels at the 
e. p. by inhibiting junctional cholinesterase. 
Later studies using extracellular recording techniques in frog and cat 
muscle, have shown that tubocurarine diminishes the a.mplitude of the 
e. p. p. by competing with the transmitter at the cholinergic receptor 
(.Jenki.rnrnn, 1960) but h:Js no effect on the time-course of the e. p. p. 
·when the e. p. p. is decreased beJ.ow threshold by tubocurarine, it is 
poss1.bh: to rec.ord a pure e. p. p. with no distortion from muscle action 
potentials. Aclr..:1inistration of physostigmine or neostigmine inereases 
the amplitude and duration of the curarized e. p. p. (Feng, 1940; Eccles, 
Katz and Kuffler, 1942 and Eccles and MacFarlane, 1949). Physostigmine 
a.lso prolong:.:> the active phase of the e. p. p. by a factor of two or three. 
Thus the t:r:ansrnittcr is acting for a longer period of time at the e. p. 
when pbysostigmine is present (Katz, 1942). 
In a non-curarized preparation (refractory) physostigmine increases 
~· 
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the amplitude and time-course of the e. p. p. When the e. p. p. is longer 
than the refractory period of the muscle fiber, repetitive discharges are 
initiated in the muscle fiber. Even in the presence of physostigmine the 
fast e. p. p. is quite rapid, indicating that a physostigmine-resistant 
mechanism of halting the action of the transmitter is occurring-probably 
diffusion. 
These results on the fast e. p. p. are compatible, and indeed broaden, 
the theory of cholinesterase inhibition. Thus it was hypothesized that 
physostigmine and neostigmine by inhibiting cholinesterase prolong the 
e. p. p .• such that repetitive activity is induced in the muscle. The 
repetitive activity gives rise to a tetanic muscle contraction. 
Physostigmine also sets up a long secondary negative potential 
change. The secondary potential has a maximal amplitude of 40% of the 
spike height and it may persist for a second or more. This wave is 
readily abolished by sub paralytic doses of curare which have little effect 
on the fast e. p. p. As these effects occur with no change in the muscle 
membrane electric time constant, and as tubocurarine has no effect on 
cholinesterase inhibition in vitro, it is difficult to explain this action of 
tubocurarine (Eccles. Katz and Kuffler, 1942). 
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Although most of the previous results were compatible with the theory 
that facilitatory drugs acted solely by inhibiting cholinesterase, n(me of 
the experiments provided conclusive evidence that prolongation of trans-
mitter action was due to cholinesterase inhibition. Thus many workers 
searched for evidence which would establish that cholinesterase activity 
at the neuromuscular junction was. decreased during the action of the 
facilitatory drugs. The most common study involved correlating inhibition 
of cholinesterase (such as, serum cholinesterase or electric eel cholin-
esterase) with the anticurare potency of these drugs (Bacq and Brown, 
1937; EccJes, Katz and Kuffler, 1942; Bulbring and Chou, 19·17; 
Blascho, Bulbring and Chou, 1949; Randall and Lehmann, 1950; Hobbigcr, 
1952 and Karc~mar and Howard, 1955) The results of these experiments 
were quite conflicting, and the probable reason for the discrep<-.ncies was 
brought Otit in a statement by Augustinsson (1959), "Plasma cholinesterases 
arc regarded as a group of esterases with nrnch divergent properties with 
regard to specificity against various choline and non-choline esters, 
se:v:1sitivity to inhibitors and activity-substrate relationships. · · ·It is not 
possible to apply results obtained with the plasma of one species to any 
other species." This statement was well illustrated with muscle 
cholinesterases by Blaber and Bowman (1962). They reported that 
ambenoniurn wcis 30 times as potent as neostigrnine in inhibiting cat muscle 
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cholinesterase, but 1/200 as potent as neostigmine in inhibiting hen 
muscle cholinesterase. Thus conclusive experiments must involve a study 
of the acetylcholinesterase of the neuromuscular junction and facilitatory 
or anticurare.aGtion of a drug at a neuromuscular junction of the same 
species. 
If cholinesterase is previously inhibited, any drug which acts by 
inhibiting cholinesterase should be ineffective. Hobbiger (1952) 
observed that previous inhibition of cholinesterase blocked the anticurare 
action of the facilitatory drugs. Neostigmine, applied iontophoretically, 
blocked pote!ltiation of the ACh-potential by edrophonium (Katz and 
Thesleff, 1957a}. Koelle (1957), using the observation that physostigmine 
pretreatment (Koster, 1946) or neostigmine pretreatment (Koelle, 1946) 
protected cholinesterase from irreversible inhibition by DFP, observed by 
histochemical methods that ambenonium and methoxyambenonium in 
concentrations, which were pharmacologically active, protected the 
junctional cholinesterase from DFP inhibition. These results indicated 
that ambenonium and methoxyambenonium were inhibiting junctional 
cholinesterase when they antagonized curare; but as stated by Koelle (1957) 
this does not show that cholinesterase inhibition was the important mech-
anism of action. 
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The facilitatory drugs cause not only potentiation of the neuromuscular 
~. -· - . 
twitch, but also depression at high doses (Bacq and Brown, 1937; Rosen-
blueth and".l\1orison, 1937;· Van Der Meer and Meeter, ·r956b arid Riker, 
--Roberts, Standaert and Fujimori, .1957) .. In toxicity .studies-this dep:r·ession 
appeared to be due to cholinesterase inhibition {Bodansky and Mazur, 1946 · 
and Nachmansohn and Field, 1947). TEPP, tetraethylpyrophosphate, cause 
a depolarization of the e. p. at high doses, but was not capable of eliciting 
a twitch ~t any dose level. Thus Douglas and Paton 0 9 54) concluded that 
TEPP induced depression of the e. p. by inhibiting junctional cholinesterase. 
Yet many workers have shown that total inhibition of cholinesterase did not 
block the indirecrr.vitch (Berry and·Ev:ons, H!~l; Barnes and Duff, 1953; 
Barstad, 1956b and Van Der Meer and Meeter, 1956a). Douglas and 
Matthews (1952) observed that TEPP blockade was readily reversible, 
even though TEPP was an irreversible cholinesterase inhibitor. On the 
basis of this type of data Barstad (19 56a) concluded that DFP, in addition 
to its cholinesterase inhibiting properties, also exhibited a curare-like 
adion at the e. p. 
The theory of cholinesterase inhibition by facilitatory drugs was 
generally accepted until 1946. Then Riker and Wescoe (1946) observed 
that neostigmine produced a contraction of skeletal muscle, even though 
the acetylcholine.sterase was previously inhibited by DFP- -
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diisopropylphosphofl.uorddatc;, a very potent. irreversible cholinesterase 
inhibitor (Mazur and Bodansky. 1946; Mackworth and Webb, 1948 and 
Michel and Krop. 1951). They concluded the primary effect of neostigmine 
. ~was a direct, depolarizing action (like ACh) at the e. p. and did not 
involve cholinesterase inhipition. Several analogues of neostigmine. 
including 3-hydroxy phenyltrimethylammonium (3-0H-PTMA). which 
facilitated the neuromuscular twitch and antagonized tubocurarine block-
ade of the twitch. also stimulated denervated muscle. As 3-0H-PTMA 
lacked the carbamate grouping which was responsible for cholinesterase 
inhibition {Stedman. 1926). Riker concluded these compounds acted via a 
direct, stimulatory action and that other facilitatory drugs had the same 
mechanism of action (Randall, 1950; Randall and Lehmann, 1950 and 
Riker and Wesco<:,1950). 
Edrophonium {3-hydroxy phenyldimethylethylammonium) was more 
specific than neostigmine in its anticurare action at the neuromuscular 
jundion--it had fewer cholinergic side effects. Randall and Jampolsky 
(1953) hypothesi?.ed that neostigmine acted by cholinesterase inhibition, 
while edrophonium acted by a direct, stimulatory action on skeletal muscle. 
Smith, Cohen, Pelikan and Unna {1952) observed that neostigmine, 
physostigmine and edrophonium exhibited direct stimulatory effects on the 
----·~· ____ .._ ____________________________________________ ,_,,_.. 
--·-
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frog rectus preparation which were 1/ 560, 1/ 75, 000 and 1/216 as effective. 
respectively. as ACh. These drugs were at least one-thousandtih1.es as 
effective in potentiating an·ACh contracture. as in producing a direct, 
. stimulatory effect. Furthermore there_ was no correlation between the 
stimulatory effect and the potentiation of ACh contractures. They conclude9 
that the effects of the facilitatory drugs on the frog rectus could not be 
due to a direct, stimulatory actiori. 
Edrophonium did not depolarize the muscle e. p. except at concen-
trations which were much higher than those necessary to produce 
facilitation of the muscle twitch in the frog (Nastuk and Alexander, 1954). 
Katz and Thesleff (1957a}, using microelectrode iontophoretic 
techniques, applied A Ch to a frog muscle e. p. If minimal doses of 
edrophonium were applied, the ACh-potential was augmented. This same 
dose of edrophonium, alone, produced no depolarization. Only at much 
highc.t" doses was edrophonium cap2.ble of depolarizing the e. p. Also, 
ech ophonium did not potentiate a depolarization due to carbachol { a 
stable choEne ester}, as would be expected if edrophonium was acting 
by a direct, depolarizing action. These results could only be explained by 
t.be theory that edrophonium inhibited cholinesterase. Although it was not 
possible to determine what concentration of edrophonium was necessary 
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to inhibit cholinesterase, these results were the first to show conclusively 
that acetylcholinesterase inhibition at the neuromuscular junction . 
produced a physiological effect- -prolongation of the action of A Ch. 
Randall (1950) and Riker (1953) suggested that displacement of tubo-
curarine from the e. p. receptor could explain the antagonistic action of 
edrophonium. Yet when tubocurarine was displaced from the receptor 
by rinsing the muscle in non-curarizedRinger, the amplitude of thee. p. p. 
was augmented with no change in time-course. Edrophonium increased 
both the amplitude and time course of the e. p. p. (Nastuk and Alexander, 
1954). 
Succinylcholine, like decamethonium, acted at the mammalian neuro-
muscular junction by depolarizing the muscle e. p. (Burns and Paton, 
Initially this depolarization increased the excitability of the 
muscle, such that facilitation of the muscle twitch occurred. After 
prolonged depolarization, there was a secondary depression of the 
muscle twitch (Zaimis, 1951). Methoxyambenonium was capable of 
antagonizing depolarization block by succinylcholine and decamethonium 
(Karczmar, 1957) and competitive block by tubocurarine (Lands, Karczmar, 
Howard and Arnold, 1955). These results seemed to contradict the 
. ·classical theory of neuromuscular pharmacology- -blocking drugs must 
act by depolarization or competition, and depolarizers and competitors 
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are mutually antagonistic. In. addition pretreatment with methoxyambenoff:-
ium increased the succinylcholine facilitation, but decreased the secondary 
, . . 
blockade. Karczmar (1957 and 1961) stated that the underlying mechanism 
of neuromuscular facilitation was more complex than originally thought 
and "may depend on more sites of action. " 
ACh was known to have a desensitizing action in isolated amphibian 
preparations (Thesleff, 1955a, 1955b and 1958 and Axelsson and Thesleff, 
1958) and methoxyambenonium readily restored the sensitivity of 
muscles which had been desensitized by ACh (Kim and Karczmar, 1967}. 
Thus a sensitizing action which had been hypothesized for other facili-
tatory drugs (zaimis, 1951; Cohen and Posthumus, 1955 and Van Der Meer 
and Meeter, 1956b} was hypothesized by Karczmar, Kim and Koketsu 
(1961) to be involved in the mechanism of action of methoxyambenonium. 
This theory was countered by other evidence. Edrophonium was not 
capable of potentiating the depolarization from an iontophoretic application 
of carbachol (Katz and Thesleff, 1957a). Blaber (1960) observed that· 
methoxyambenonium and ambenonium exhibited curarimimetic properties 
at doses higher than were necessary to antagonize tubocurarine. Thus it 
was concluded that antagonism to depolarizing block was due to this 
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curarimimetic activity and not due to sensitization. This was further 
supported by the observation that succinylcholine blockade was an,tagonized 
by appropriate mixtures of neostigmine and tubocurarine (Blaber and 
Karczmar,-'1967a and1967b). 
Masland and Wigton (1940) investigated the origin of spontaneous 
twitching which occurred after administration of facilitatory drugs (Langley 
and Kato, 1915). Upon administration of neostigmine, spontaneous 
antidromic action potentials and antidromic potentials after an indirect 
stimulus were recorded in the ventral root of the cat spinal cord. Masland 
and Wigton concluded that the antidromic impulses originated in the region 
of the motor n.e:rve endings. As ACh also produced the spontaneous activity 
in the nerve it seemed likely that neostigmine acted by causing an 
accumulation of ACh at the neuromuscular junction, thus allowing ACh 
to act at the nerve endings (Eccles, 1964 and Hubbard, 1965). 
Physostigmine also produced antidromic activity in the cat. Feng 
and Li (19,11) co:1clnded that physostigmine acted directly on the 
presynaptic nerve endings in the mammalian preparation. Yet there was 
not complete correlation between repetitive firing of the nerve and 
repditive firing of the muscle. Due to this inconsistancy, it seemed 
likely that the nerve terminal was not the site of drug action, but was 
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merely stimulated by the prolonged e. P~ current in the presence of 
physostigmine (Eccles, Katz and Kuffler, 1942). Antidromic activity 
was obvious in the nerve following direct stimulation of the muscle. 
After indirect stimulation the repetitive activity of the muscle appeared 
to occur earlier than the repetitive activity in the nerve. Also, antidromic 
activity occurred in.nerves which were not stimulated and was· decreased 
when the, nerve stimulus was desynchronized. These results indicated 
that muscle action potentials were capable of depolarizing the nerve 
terminals, such that antidromic activity was initiated. This depolarization· 
of the nerve terminal in turn induced repetitive activity in the muscle, 
resultjng in a tetanic-like twitch (Lloyd, 1941 and 1942 and Brown and 
Matthews, 1960). According to these theories all the effects of 
physostigmine can be explained on the basis of in'hibition of junctionaJ 
cholinesterase. 
Barstad (1962} observed that antidromic nerve discharges could 
be elicited t:ven though the muscle fibers were cut and could not respond 
to a stimulus. Upon more careful examination, two types of antid~omic 
11crve activity were observed by Werner (1960a, · 1960b and 1961) in the 
presence of the facilitatory drugs. The early phase had a very short 
latency and was due to the ephaptic backfiring from the muscle action 
potentials as described by Lloyd and Brown and Matthews. But there was 
also a secondary phase of antidromic activity which had a longer latency. 
This secondary phase could only be explained by the theory that a long 
generator. potential occurred in the .motor -nerve terminal (Werner, 19 60b). 
This generator potential probably was the negative afterpotential of the 
nerve terminal spike. Thus paired stimuli with a short interval increased 
the antidromic activity in the nerve and paired sUmuli of a long interval 
depressed antidromic activity in the nerve (Werner, 1960a and Blaber 
and Bowman, 1963b}. This theory was supported by the observation 
that antidromic activity which occurred in unstimulated nerve fibers had 
a short latency. The secondary activity, which had a longer latenc:y, 
occurred only in nerve fibers which had been stimulated ·(Werner, 1961). 
There was one discrepancy in these results. Werner (1960a) by 
using paired stimuli concluded that the negative afterpotential of the motor 
nerve terminal had a duration of only 5 msec. Yet the antidromic activity 
after an orthodromic stimulus in the presence of a facilitatory drug had 
a much longer duration; thus Blaber and Bowman (1963b) concluded that 
the negative afterpotential was also longer. The short duration observed 
by \Verner (1960a) was probably due to extinction of orthodromic stimuli 
by antidromic stimuli (Blaber and Bowman, 1963a}. Hubbard, Schmidt 
> ' 
and Yokota (1965) also observed a longer duration for the negative 
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afterpotential of the motor nerve terminal. 
Pentobarbital, procaine and cyclopropane blocked antidromic nerve 
activity induced by 3-0H-PTEA (3 hydroxyphenyltriethyla...mmonium), but 
these anesthetics had no effects on the facilitation of neuromuscular twitch 
which was produced by 3-0H-PTEA {Riker, Werner, Roberts and 
Kuperman, 1959). Thus the nerve terminal generator was distinguished 
from the muscle generator of repetitive activity. Tubocurarine blocked 
the nerve terminal generator potential at lower doses than it blocked 
the ephaptic activity. On the basis of these results it was concluded 
that the safety factor for axonal excitation by the terminal generator was 
narrow·er than the safety factor for transmission to postSynaptic units 
(Werner, 1959 and 1961). 
The facilitatory drugs produced facilitation of the mammalian 
neuromuscular twitch, rather easily. The amphibian muscle was much 
less respon_sive to the actions of these drugs (Raventos, 1937), although 
it was possible to produce facilitation of the amphibian muscle twitch 
with physostigmine or edrophonium, when a stimulus rate no greater 
than one per minute was used {Feng, 1937; Hodes and Steiman, 1939 
·and Nastuk and Alexander, 1954). This difficulty in obtaining facilitation 
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was paralleled by a lack of antidromic activity in the presence of the 
facilitatory drugs (Dun and Feng, 1940). These results may point to a 
fundamental difference in the pharmacological action of the facilitatory 
drugs at the mammalian as compared to the· amphibian neuromuscular 
junction {Blaber and Karczmar, 1967b). 
Riker and co-workers (1957) began an investigation of the nerve 
terminal activity of a series of phenolic compounds. These compounds · 
wer~ structurally similar to neostigmine. except they were considerably 
less potent than neostigmine in inhibiting acetylcholinesterase. 3-0H-P'IMA ·. 
facilitated the neuromuscular twitch at low doses and blocked the neuro-
muscular twitch at high doses. When the hydroxyl group was eliminated, 
as in PTMA (phenyltrimethylammonium) or PTEA {phenyltriethylammonium , 
the ability to facilitate the twitch was lost. As 3-CH3-PTMA (3 methyl-
phenyltrimethylammonium) was ineffective. the ability to facilitate the 
twitch seemed to require the presence of a hydroxyl or carbamyl grouping 
in the meta position. The meta grouping was also necessary to initiate 
antidromic activity in the motor nerve. On the basis of these results 
Riker, Roberts, Standaert and Fujimori (1957) concluded that 
3-0H PTMA and its analogues which also facilitated the twitch produced 
their facilitatory effects by an action on the motor nerve terminal 
(Kuperman, Gill and Riker, 1961). As the ethyl analogues showed 
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no depression, they further concluded that the depressing activity was due 
to depolarization and was related to the number of methyl groups on the 
' ' quaternary nitrogen (Randall, 19 50 and Smith, Cohen, Pelikan and Unna, 
1952). 
Edrophonium, ambenonium and neostigmine facilitated the neuro-
muscular twitch and induced antidromic activity in the ventral root. 
Mcthoxyambenonium depressed the sensitivity of the e. p. and nerve termina 
and probably, for this reason could not facilitate the muscle twitch or 
induce antidromic nerve activity (Blaber, 1960). Goode, Blaber and 
Karczmar (1965), using Koelle's (1957) technique, observed that it was 
possible to facilitate neuromuscular transmission with doses of edrophon-
ium and neostigmine which did not protect cholinesterase from inhibition 
by DFP. This may indicate another mechanism of action for these drugs 
although such a conclusion, at least with edrophonium was not completely 
justified as kinetic studies have shown that inhibition of cholinesterase by 
edrophonium was very rapidly reversed, and therefore could not be 
expected to protect from DFP (Wilson, 1955 and Katz and Thesleff, 1957a). 
Intravenous edrophonium and close-arterial edrophonium and 
neo~~tigmine facilitated the neuromuscular twitch but did not increase the 
contracture from close-arterially injected ACh. Methoxyambenonium 
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(intravenously or close-arterially) antagonized tubocurarine but did not 
augment the ACh-contracture. If the facilitatory d:rugs acted by inhibiting 
junctional cholinesterase, the ACh-contracture and indirect muscle twitch 
should be increased at the same dose. Furthermore, there was rto corre-
lation between facilitation or anticurare action and the cholinesterase 
• 
inhibiting acUvity of these drugs. On the basis of these results Blaber 
and Bowman (1959 and 1963a) and Blaber (1960 and 1963) concluded that the 
facilitatory drugs produced their effects by a direct action on the motor 
nerve terminal. 
The development of unicellular recording techniques opened a new 
realm in which to study the effects of drugs at the neuromuscular junction. 
Fatt and Katz (1950 and 1952) in their early experiments in the frog 
observed that neostigmine increased the amplitude and half-decay time, 
but not the frequency of m. e. p. p. s. As hypothesized by Katz (1958 and 
1962) experimental changes of m. e. p. p. time-course involve a postsy-
napUc rnechanism while experimental changes of m. e. p. p. frequency 
involve a presynaptic mechanism. Liley (1956a) reported similar obser-
vations vvith neostigmine in the rat diaphragm, but Boyd and Martin (1956a) 
observed small increases in the frequency of m. e. p. p. s in the cat 
tenuissimus. 
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Neostigmine augmented the amplitude of a curarized e. p. p. (Fatt 
and Katz, 1951 and Boyd and Martin, 1956b) but produced relatively 
small changes in the time-course. Neostigmine greatly prolonged the 
time-course of an e. p. p. which was recorded in a ringer solution that had 
20% of the control sodium ion concentration (Fatt and Katz, 1951). IncreasN 
of the e. p. p. were accompanied by proportional increases in e. p. current 
(Takeuchi and Takeuchi, 1959). 
Several drugs have been shown to produce effects on the e. p. p. which 
are very similar to those reported for neostigmine, but these drugs do not 
act by inhibiting junctional cholinesterase. TEA(Stovner, 1958 and 
Koketsu, 1958), guanidine (Otsuka and Endo, 1960b) and phenol (Otsuka and 
Nonomura, 1963) have been s_hown to increase the release of transmitter. 
Thus the present investigation will be undertaken to try to determine the 
mechanism by which the facilitatory drugs produce their effects at the 
. 
neuromuscular junction. The drugs which will be used are: l)ambenonium, 
a very potent acetylcholinesterase inhibitor; 2) neostigmine, a classical 
facilitatory drug; 3) edrophonium, a potent facilitatory drug which has 
been reported to be a very weak acetylcholinesterase inhibitor and 4) 
methoxyambenonium, a potent antagonist of tubocurarine blockade that is 
not able to facilitate the maximal muscle twitch. It also has weak acetyl-
. ' 
cholinesterase inhibiting properties. 
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METHODS 
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I. Anatomy of the Tenuissirnus Muscle of the Cat 
All experiments were performed on the tenuissimus muscle of the cat. 
This muscle was chosen as it. is very similar pharmacologically to the 
gastrocnemius and tibialis muscles which have been used in in vivo studies 
(MacLagen. 1962). The tenuissimus muscle originates from the trans-
verse process of the second caudal vertebra. It lies between the biceps 
femoris and semimembranous muscles in the sciatic notch and inserts on 
fascia of the shank (Hyman. 1962). As the tenuissimus muscle is quite 
long ()5 cm.) and thin (1 mm) it makes a very good isolated tissue 
preparation. Ringer solution can reach most of the fibers in the muscle, 
whiclJ. i::> :o.ot ~.i:ue of such large muscles as the tibialis o.ntcrior a;.-1d 
gastrocnemius. The tenuissimus nerve arises from the sciatic nerve. 
Just before entering the tenuissimus muscle. the nerve trunk divides - -
one branch passing anteriorly and the other branch passing posteriorly - -
and enters the muscle. Each branch passes superficially down the middle 
of the muscle giving off nerve fibers to the muscle fibers. 
It. Removal of Muscle 
Cats were anesthetized with 70 mg/kg alpha-chloralose intraperitoneall . 
5 mg/kg pentobarbital sodium facilitated induction and 1. 5 mg/kg atropine 
aided in blocking mucous secretions. The sciatic notch was 
50 
opened to expose the tenuissimus muscle and nerve. The tenuissi.mus 
nerve was dissected free from the sciatic nerve so that a segment of nerve 
about 3 cm long could be obtained. The muscle was then dissected free. 
In general, the distal portion of the mu~cle (below the entry of the nerve) 
was used in the experimental procedure. The muscle was placed in a 
muscle bath .. Removal of connective tissue from the muscle made it 
possible to see the superficial nerve fibers with the aid of a microscope. 
Pinning the muscle securely to the bottom of the bath eliminated extra-
neous movements. The ends of the muscle were then cut distal to the pins. 
The nerve was placed over the bipolar platinum electrodes (5mm apart) 
in a separate compartment of the bath (except in m. e. p. p. studies when 
the nerve was not removed from the animal). 
III. Perfusion of Muscle 
Krebs solution was used to supcrfuse the isolated tissue. All reagents 
except NaCl,. D-glucose, and NaHC03 were kept in stock solutions. Thus 
addition of 2 ml of each of the stock solutions to a liter of distilled water 
gave the proper concentrations (Table 1) (Boyd and Martin, 1956a). The 
NaCl, D-glucose, and NaHC03 were measured as dry weight. This 
solution was aerated with 95% o2 and 5% co2 through a sintered glass 
aerator in a 50 ml bath before passing into the isolated muscle bath. 
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Table 1 
·· · -········Composition of the Kreb's solutfon superfusing 
the isolated tenuissimus muscle. 
NaCl 115 mM 
KCl 4. 60 mM 
KH2P04 1.15 mM 
NaHC0 3 24.1 mM 
Cr· C'l d. , 2 2. 46 mlVI 
JVIgS04 1.15 mM 
Glucose 8. 85 mM 
I l~.__:·x..: ... ~~~~-~·.~:,~ ... ~~+-..~ .. ~~..cm:::z.&: ..... ~~~-~~~~" 
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(Another bath was used for drug-Krebs solution. ) The 50 ml bath had a 
wann water jacket, controlled by a Haake constant temperature c ircu-
f' 
lation pump. so that the temperature of the Krebs solution was raised to 
.. zpproximately 40°G •... The Krebs .solution then flow_e.d ___ int.o tn_e __ m~s_cle 
bath via a narrow diameter (PE 90 - I. D. 0. 03411 , O. D. 0 .. 050") poly-
ethylene tubing of approximately 16 inches in length. The tubing also ran 
through a warm water jacket again to reach a constant temperature before 
entering the muscle bath. The polyethylene tubing was placed in the 
muscle bath and the Krebs solution was allowed to run freely into the 
muscle bath. The flow was constant for any experiment (200-250 ml/hr) 
and was determined by the length of polyethylene tubi.ng and height of the 
50 ml bath. The temperature was constant {it depended mainly oi: flow 
rate) but could. be varied by a temperature control on the circulation 
pump such that the final temperature in the muscle bath was constant at 
approximately 37°C (36-38°C). 
The muscle bath had the following dimensions - - 0. 6 cm x 8. 0 cm 
x O. 5 cm. The nerve compartment measured 1. 0 cm x 1. 0 cm x 0. 5 cm. 
Thu_s the total volume of the bath was approximately 3 ml. This allowed 
for rapid turnover of solutions { 2x volume in 1. 5 min. ) with a minimal 
amount of movement. The solution was removed by overflow into a drain. 
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The only adjustment necessary to change to new solution was to move a 
clamp from one tubing to another. The rate and final temperature were 
constant throughout the experiment. A muscle could be maintained for 
at least 10 hours without significant decay of membrane potential or 
neuromuscular transmission. 
IV. The Making and Filling of Electrodes 
Microelectrodes were made from pyrex capillary tubing (0. 1 cm 
diameter - 7 cm length) The tubing was pulled to a narrow tip with a 
David Kopf #700 vertical pipette puller using nichrome heater coils. The 
electrodes were floated on distilled water and examined under a micro-
scope (lOOx magnification factor) to obtain a rough estimate of the tip 
size (determined by distance water passes up electrode) and general 
contour of the tip and shank of the electrode .. Only those electrodes with 
narrow tips (little water passing in) and narrow shanks were filled. A 11 
others were discarded. The electrodes were then boiled in filtered 
methyl or ethyl alcohol for 3 minutes using a Precision Scientific 
vacuum pump to fill the electrodes with alcohol. The alcohol was then 
replaced with distilled water by immersing the alcohol filled electrodes 
in filtered distilled water for 30 minutes. Finally, the electrodes were 
immersed in filtered 3M KCl until the day of use (at least 24 hours). 
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When electrodes were made for iontophoretic studies, they were immersed 
in ACh or carbachol (0. 3 M to 3M), rather than KCl. By storing in a 
refrigerator, these electrodes were usable for periods up to several months 
V. Recording Appartus 
Recordings were made using the intracellular technique developed 
by Ling and Gerard (1949) and Nastuk and Hodgkin (1950). The electrode. 
was supported in a glass tubing (I. D. 0. 2 cm) which was filled with an 
agar - 3 M KCl column. The agar - 3 M KCl column made connection 
with a silver chloride coated-silver wire spiral to eliminate a junction 
· potential. Ail indifferent electrode which made contact with Krebs 
solution consisted of an agar ,.. Krebs column in contact· with a silver-
silver chloride spiral wire. (The silver wire spiral was coated with 
silver chloride by electrolysis in 0. 1 N HCl. (2Cl- + Ag ----+ 
AgC12 + 2 e:-.)) The.-two-inputs (one from each agar bridge) were 
connected to a Nikkon hi-input impedance amplifier. The output of this 
pre-amplifier led into a Tektronics Type 502 dual beam oscilloscope. 
This trace was used to monitor the membrane potential of the muscle cell. 
A second output from the preamplifier led into a Tektronics Type 122 
low-level preamplifier. This output led into two Tektronics Type 502 
dual. beam oscilloscopes. r_r:he first oscilloscope which was monitoring 
i 
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JQ.cket 
J.f7 K.Q 
..•. 
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the membrane potential (low gain) was also used as a monitoring scope 
for the end-plate phenomena (high gain). The second oscilloscope had 
only the end-plate phenomena and was used for recording purposes. 
Permanent records were made with an Analab oscilloscope camera. Thirty 
five millimeter still or continuous motion pictures could be taken of the 
potentials depending on the particular experiment. 
VI. Selecting an Electrode 
Electrodes were selected on the basis of their resistance and abiiity 
to penetrate the muscle fiber without causing considerable damage. [n 
general, a resistance of less than 20 megohms was necessary to make:: 
the noise level sufficiently small to record miniature potentials. If the 
resistance was less than 5 megohms, the electrode tip was usually too 
large and therefore damaged the muscle fiber. After an electrode of t11e 
correct resistance had been obtained, the electrode was placed in several 
rr:uscle fibers. If the electrode gave a deflection equivalent or greater 
than 60 m V and there was no significant decay of the resting membrane 
potential, ihe electrode was considered usable. If there were no 
deflections of greater than 60 mV for resting membrane potentials, or 
the resting membrane potenticil decayed constantly, the electrode was 
discarded. An AC square wave signal was passed through the electrode 
-----------------------·----------------------------------------------------. 
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and by means of a capacity compensator in the Nikkon hi-input impedance 
amplifier, it was possible to keep the time-constant of the system below 
70 µsec. 
VII. Locating an End-Plate and Recording M. e. p. p. s 
Connective tissue on the surface of the muscle was removed to expose 
the nervous structure of the muscle (small superficial branches come 
off a large central nerve). The superficial nerve branches were located 
with the aid of a binocular stereo microscope (magnification - 15x). The 
microelectrode and indifferent electrode were carried on a Narishige 
micromanipulator. The microelectrode was generally inserted in the 
area of a small superficial nerve. As a result, the prob.ability of 
locating an e. p. was quite high. The presence of m. e. p. p. s indicated 
that the electrode was near the e. p. region of the muscle. 'The electrode 
was usually reinserted into the muscle until a point was found where the 
m. e. p. p. s were of maximal amplitude and shortest time-course. 'The 
resting membrane potential was also recorded to show that the muscle 
fiber was in good condition and not decaying over a long time period. 
Pictures of them. e. p. p frequency were taken on a slow sweep (O. l cm/sec) 
and tirne course were taken on a rapid sweep ( 2 msec/ cm). 
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VIII. Locating an End-Plate and Recording (+)-Tubocurarine, High 
Magnesium and Benzoquinonium E. p. p. s 
The nerve to the tenuissimus muscle was placed over bipolar platinum 
electrodes (0. 5 cm apart) in a separate compartment of the bath. The 
nerve was stimulated at 2 x maximal voltage with a pulse of 50psec at a 
rate of 1/2. 5 to 1/10 stimulus per second. The muscle twitch was blocked 
by tbe lowest possible concentration of (+)-tubocurarine (2 to 5 pg/ml), 
benzoquinonium (1. 5 to 3 pg/ml) or decreased calcium and increased 
magnesium. The blocking agent was added to the Ringer solution and 
infused through a second 50 ml bath system. An ~- p. p. was localized in 
a manner similar to that for the m. e. p. _µ. s. Amplitude was the major 
criteria. An amplitude of greater than 3 mv was genera1ly used (except 
in quantal content studies). The half-decay was usually below 2 msec 
(rise to one-half fall) and the rise-time was less than 1 msec. This e. p. p. 
was then used as control for drug-induced effects. 
IX. Iontophoretic Application of Drug§ 
In this series of experiments the recording apparatus was the same as 
previously described, except only DC-amplification was used. The muscle 
twitch was always blocked with (+)-tubocurarine (4 pg/ml). The 
iontophoretic electrode (with A Ch or carbachol) was supported in a 
~ccond mj cromanipulator. Two stimulators were necessary, one to 
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eject the drug and ci.notber to retard diffusion of the drug from the tip of the 
eiectrode. Each stimulator was connected to an.isolation unit. The two 
isolation units were connected in series, with one lead from the isolators 
_pas.~ ing_ thr9_ugt~ __ _a. 2_q_ m~_g()hI? r_~Ej~S-~~~c~ _ in!o_ t?e.. iontophoretic electrode._ 
-----------·--- , _____ , ·-- ----·· . -
The other lead passed through 47 kohm resistance into the bath .. The end 
of each lead was coated with silver chloride. By recording the voltage 
change across the 47 koh:in resistance it was possible to determine the 
amount of current {as ACh or carbachol) which passed from the electrode. 
This current recording was used as a monitor to be certain that equal 
dosE:s of drug i.,vere ejected with each pulse. 
After an e. p. p. had been located, the iontophoretic electrode \V8.S 
moved into the region of the e. p. By careful manuevering of this 
electrode, it was possible to produce a rapid depolarization of the e. p. 
from application of ACh or carbachol. These drug-induced potentials 
remainea relatively constant fri amplitude and time-course. Rapid 
iontophoretic potential.s {half-decay less than 100 msec) required precise 
localization at the e. p. Any movement produced large changes in the 
iontophoretic potential. As these experiments required long infusion times, 
it seemed desireable to use slower potentials {100 to 500 rnsec half-decay). 
Then movements were not so critical. The pulse voltage and duration for 
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drug ejection were varied such that the amplitude of the iontophoretic 
potential was similar to the amplitude of the e. p. p. The braking current 
(opposite polarity) was adjusted, such that no decay of the membrane was 
obvious from diffusing drug. 
X. Infusion of Facilitatory Drugs 
The agents used were neostigmine bromide, edrophonium chloride, 
ambenonium chloride, and methoxyambenonium chloride. The facili-
tatory drug was added to a volume of the control Krebs-Ringer solution 
and infused through a second 50 ml bath. The initial concentration of the 
facilitatory drug was 10 -B M (except in the case of ambenonium where 
-10 -1'> due to its high potency, the initial concentration was 10 ~M or 10 ""M) 
and the concentration was increased by IO times every 15 - 20 minutes 
until a predominate postsynaptic action occurred - twitching, depolarizing 
(decreased amplitude and decreased resting membrane potential) or 
competitive blockade (decreased amplitude but no effect on the resting 
membrane potential). The muscle was then returned to a control Krebs-
Ringer solution to determine if the drug was reversible or irreversible. 
Drugs were infused for a period of ten minutes before recordings were mad 
XI. Measuring the End-Plate Phenomena 
The film which had been exposed to the e. p. phenomena was projected 
on a Durs.t, 606 Enlarger such that the potentials were magnified 2. 5x in 
61 
__ .order to make the necessary measurements. 
M. e. p. p. frequency was determined from a series of traces which were 
fihned at a sweep speed of 0.1 sec/ cm or I sec/ sweep for a period of 25 
seconds. Five such samples were taken at 2 minute intervals for each 
experimental situation. The standard error of the five samples was 
calculated as well as t-values for significant changes due to the drugs. 
M. e. p. p. time-course was recorded on fast multiple sweeps (2 
msec/ cm) by holding the camera shutter open until a m. e. p. p. occurred 
on the monitor scope. This resulted in a thick base line. In each 
experimental situation, 10 m. e. p. p. s were measured for 1) amplitude, 
2) rise-time, and 3) half-decay time and the average was calculated. 
E. p. p. s were also recorded on a fast sweep (2 msec/ cm) which 
could be triggered to give a single sweep. Again the 1) amplitude, 2) 
rise-time and 3) half-decay time were measured from ten samples in 
each experimental situation. 
In iontophoretic studies e. p. p. s and iontophoretic potentials were 
recorded on single, slow sweeps (100 to 500 msec/ cm). 1) E. p. p. ampli-
tude and iontophoretic potential 2) amplitude 3} rise time and 4) half-
decay time were measured from five records for each experim;ental 
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condition. 
Standard deviation and t-values were calculated for each group of 
samples. 
The effect of facilitatory drugs on quantal content was calculated from 
the number of e. p. p. failures during 200 nerve stimuli with decreased 
c~lcium (O. 9:?nM) and increased magnesium (5-7 mM) ion concentrations 
or by comparing the amplitudes of 50 m. e. p. p. s and 50 e. p. p. s with 
increased magnesium ions (12-15 mM) (Del Castillo and Katz, 1954c). 
RESULTS SECTION 1 
EFFECTS OF FACILITATORY DRUGS ON 
M. E. P. P. SAND (+)-TUBOCURARINE E. P. P. S. 
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INTRODUCTION 
' 
Several microelectrode techniques are commonly used to dis -
tinguish presynaptic and postsynaptic ~echanisms of drug action. The 
most direct technique involves the effects of drugs on m. e. p. p. frequency 
and time-course (Katz, 1958, and 1962). Also, a comparison of the ampl~-
tude and time-course of m. e. p. p. s and e. p. p. s, and observation of the 
e. p. membrane potential at various drug concentrations should enable a 
distinction between: 1) a direct, depolarizing action, 2) sensitization of 
the e. p. receptor, 3) cholinesterase inhibition and 4) a pre-junctiona1 
action. 
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RESULTS 
Effects of neostigmine on m. e. p. p. s 
The effect of neostigmine on m. e. p. p frequency was to produce a 
small but significant increase in three out of four experiments. The 
effects on frequency were not readily reversible and the frequency re-
mained at the increased level after the muscle had been returned to 
Krebs solution for 90 minutes. 
No effects on amplitude or rise-time were noted when the perfusion 
solution contained 10- 8M neostigmine. With 10-7M neostigmine. the 
increase in both the amplitude and the time course became very significant 
(P'= O. 001) and the parameters were further increased by 10- 6M neostig-· 
mine. With 10-5M the amplitude and time course of m. e. p. p. s. decreased 
as the membrane potential fell from 60 to 39 mV. At 10- 6M the amplitude 
increased by 67%. the rise-time by 86% and the greatest increase was the 
half-·decay which increased by 188%. The effects on amplitude and time 
course, and the depolarization of the end-plate membrane were all 
reversed after returning the muscle to Krebs solution for 90 min. An 
example of the effects of the neostigmine on m. e. p. p. s. is given in 
Table 2A. 
TABLE 2A 
Effects of Neostigmine on M. e. p. p. s. 
Frequency 
' 
' Concentration of 
.. 
I Membrane 
i 
of m. e. f,· p. s Amplitude Rise-time Ealf-decw potential 
neostigmirie (M) (sec- )a: (mV)b (msec)b (msec) (mV) 
Control 1. 9+0. 4 . o. 6+0. 1 0.7+0.l 0.8+0.2 T 61 
10-8 c 0.7+0.2 o. 7+0. 1 o. 9_:!:0. 3 i 61 
10- 7 2. 4,+0. 2* 0.9+0.2** 1. 0+0. 2** 1. 6+0. 4** 65 
' 
10-6 ' 2.5+0.3** 1. o+o. 2** 1. 3+0. 3** 2.3+0.7** 60 
10-5 39 
a + Standard error of the mean. 
b + Standard deviation. 
c Film recording poor with this observation for accurate measurement, but no change in frequency 
was apparent. 
* Diff e!'ence statistically significant at 1 % level. 
>!<>:< Difference statistically si.gnificant at O. l % level. 
M. e. . n. s too small to me::i.sure accuratel . 
TABLE 2B 
Effects of Neostigmine on E. p. p. s. (2 ug/ml Tc) 
Concentration 
of Ampli~de 
neostigmine (M) (mV) 
Control 5.4+0.2 
10- 8 6.9+0.3** 
10- 7 8.5+0.3** 
10-6 Muscle began 
to twitch 
a + Standard error of the mean. 
b + Standard deviation. 
Rise-time Half-decay 
(msec)b (msec)0 
0.6+0.l o. 9+0. 1 
o. 6+0. 1 0.9+0.l 
o. 8+0 . .1* 1. 3+0. l** 
Membrane 
potential 
(mV) 
68 
68 
68 
c Jfilm recording poor with this observation for accurate measurement, but no change in frequency 
was apparent. 
>:< Difference statistically significant at 1% level. 
•:
0 :c Difference statistically significant at 0. 1% level. 
--- M. e. p. p. s too small to measure accurately. 
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Effects of neostigmine on (+)-tubocurarine e. p. p. s. 
At 10- 8M neostigmine, a very significant increase in amplitude was 
produced with no change in-time course: -~he amplitude and time course 
both increased at 10~ 7M neostigmine; however, the increase in amplitude· 
was greater (57%) than the increase in rise-:-time (33%) or half-decay 
(44%). At l0- 6M neostigmine the muscle began to twitch and the record-
ings were lost. Table 2B illustrates the effects of neostign1ine on single 
e.p.p.s. 
~ffects of edropJ:i_?.nium on m. e. p. p. s 
In four experiments infusion of concentrations of edrophonium of 
10- 8M or greater produced a very significant increase in m. e. p. p. fre-
quency (Figure 1). This effeCt was reversed after the muscle had been 
-returned to Krebs solution for 60 min. (Table 3A). 
There were no significant changes in amplitude or time course of the 
m. e. p. p. s. with edrophonium concentl·ations up to 10- 5M. At 10-4M the 
e. p. . membrane potential was depolarized to 4lm V and the m. e. p. p. s. 
were no longer visible. The control readings were again obtained 60 
min after the infusion of drug solution had been replaced by Krebs solution. 
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Figure 1. The effect of edrophoniµm on m. e. p. p. frequency. (a) Control 
(b) In the presence of edrophonium 10- 8M. Voltage calibration, 1 m V; 
time calibration, 0. 2 sec. 
..--------------------------------------------------..-..·\----.... ·, 
I 
' 
TABLE 3A 
Effects of Edrophonium on M. e. p. p. s 
Frequency 
Concentration of i Membrane 
of m. e. P·R· s Amplitude Rise-time Half-decay potential 
edrophonium {M) (sec- )a (mV)b {msec)b (msec)b (mV) 
Control 1. 7+0. 1 0.6+0.2 1. l+O. 2 1. 4+0. 3 70 
10-8 2.7+0.4** o. 6+0.1 1. 2+0. 2 1. 3+0. 3 70 
10-7 2.8+0.5** o. 6+0.1 1. o+o. 2 1. 5+0. 3 71 
-6 
10 2. 5+0. 2** 0.7+0.2 1. 3+0. 2 1. 5+0. 3 70 
10- 5 2.5+0.2** 0.6+0.2 1. 2+0. 1 1. 5+0. 2 66 
10-4 48 
For symbols see Table 2A. 
-------------------------------------------~\----c, . .- .\ I, 
TABLE 3B 
Effects of Edrophonium on E. p. p. s (4 µg/ml Tc) 
Concentration Membrane 
of Amplitude Rise-time Half-decay potential 
edrophonium (M) (mV)b (msec)b (msec)b (mV) 
Control· 3.5+0.2 0.7+0.l 0.9+0.l 65 
10-8 3.6+0.l 0.7+0.l 0.9+0.l 65 
10-7 4.0+0.2** 0.7+0.l 1. 0+0, 1 65 
10-6 5,5+0.2** o. 8+0. 1 1. 2+0, l** 65 
10-5 9,3+0,3** 1. 2+0. l** 2.4+0,l** 65 
Muscle began to twitch 
For symbols see Table 2A. 
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Effects of edrophonium on (+)-tubocurarine e. p. p. s. 
In three experiments 10-SM edrophonium produced no significant 
changes in the amplitude or time course of the e. p. p. s; l0- 7M increased 
the amplifude with no-·changein time cour::re~--ct(J'"-6M and10-=5M increased 
both amplitude and time course. At 10-GM the increases were:amplitude 
57%, rise-time 14%, half-decay 33%, and at 10- 5M, amplitud~ 165%, 
rise-time 71% ancl half-decay 167%. Ten minutes after perfusion with 
10- 5M edrophonium, the muscle began to twitch and the recording was 
lost (Table 3B). 
Effects of ambenonium on m. e. p. p. s 
In four experiments ambenonium did not produce any significant 
increase in m. e. p. p. frequency. In the experiment illustrated by Table 
-9 -8 4A, the frequency decreased at 10 M and 10 M but there was no change 
at 10-7M. The amplitude and time course were very significantly increased 
at concentrations of 10-6M and 10- 7M At l0- 7M the amplitude was 
increased by 71%, the rise-time 57%, and the half-decay 1 70%. The half-
-6 -5 decay decreased at 10 M and the m. e. p. p. s disappeared in 10 M 
ambenonium. The m. e. p. p. s returned when the drug solution was replaced 
by Krebs solution at the increased amplitude and time course which did not 
return to control values after three hours perfusion. 
~~--=_....._,.,,__,._ __ _..,,....._.,.... __ ..., __ _.._.._.~-=-•nm,___......., ____ _,, _______ ....,._,.. ____ ,_., 
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L 
P."'igure 2. The effect of ambenonium on e. p. p. and m. e. p. p. amplitude and 
time course. (a) .E. p. p. s. recorded in the presence of 5 µg/ml tubocu-
rarine; A--control; B-- with 10-9M ambenonh:_rf; C--with 10-8M ambenon-
ium. (b) M. e. p. p. s.: A--control; B--with 10 M ambenonium. The thick 
base line is due to the record being photographed from a recurrent sweep, 
the camera shutter being left open until a m. e. p. p. occurred. Voltage 
calibration, (a) 5 m V, (b) O. 5 m V; time calibration, (a) I msec. {b) 1 msec. 
--· 
TABLE 4A 
Effects of Ambenonium on M. e. p. p. s 
Frequency 
Concentration of Membrane 
of m. e. p. p. s Amplitude Rise-time Half-dec~y potential 
ambenonium (M) (sec-l)a (mV)b (msec)b (msec)b (mV) 
Control 1. 5+0. 1 0.7+0.l o. 7+0.1 1. O+O. 3 66 
10-10 1. 3+0. 3 0.7+0.l 0.7+0.l 1. l+O. 2 65 
10-9 1. l+O. 3** 0.7+0.l o. 7+0. 1 1. o+o. 2 61 
10-8 1. 2+0. l** 0.8+0.2 o. 8+0.1 1. 3+0. 3 58 
10-7 1. 5+0. 2 1. 2+0. l** 1.1+0. 2** 2.7+0.4** 56 
10- 6 1. 3+0. 2* 1. 2+0. l** 1. l+O. 2** 2.3+0.6** 60 
10- 5 65 
Note: Changes in m. e. p. p. frequency show a statistically significant decrease. 1 
For symbols see Table 2A. 
TABLE 4B 
Effects of Ambenonium on E. p. p. s. (5 µg/ml Tc) 
Concentration Membrane 
of Amplitude Rise-time Half-deca:b potential 
ambenonium (M) (mV)b (msec)b (msec) (mV) 
Control 5.8+0.3 0.7+0.l 1. O+O. 1 
10-10 6.3+0.2** 0.7+0.l 1. o+o. 1 78 
10-9 6.5+0.3** 0.7+0.l 1. o+o. 1 78 
10-8 13. 8+0. 7** 1. l+O. l** 1. 8+0. l** 80 
10-7 Muscle began to twitch 
For symbols see Table 2A · 
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When using ambenonium, it was difficult to maintain a stable end-
plate membrane resting potential throughout a complete experiment due to 
the muscle twitching at concentrations between 10-9M and 10-7M. The 
shift in membrane potential in the experiment illustrated in Tab le 4A was 
not due to depolarization but due to movements of the electrode caused 
by the muscle twitching. In some experiments it was possible to observe 
a stable resting potential up to a concentration of 10-8M. In these experi-
ments there was no change in amplitude or time course of the m. e. p. p. s 
with 10-10M or 10-9M. However, there were significant changes in 
amplitude, rise-time and half-decay at 10-8M and, therefore, the change 
in membrane potential shown in Table 4A did mask changes occurring 
with 10- 8M ambenonium. 
Effects of ambenonium on (+)-tubocurarine e. p. p. s 
In three experiments 10-lOM and 10-9M ambenonium produced a very 
significant increase in e. p. p. amplitude with no change in time· course 
(Figure 2). At 10- 8M the amplitude was increased by 138%, the rise-time 
-7 by57% and the half-decay by 80%. At 10 M the muscle began to twitch 
and no further recordings were possible. (Table 4B). 
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Effects of methoxyambenonium on m. e. p. p. s 
' In three experiments methoxyambenonium produced a significant 
jrtcrease in m. e. p. p. -frequency at-10-:~M.---No-significant increase in 
amplitude or rise-time was observed. The half-decay increased at 10-7M · 
and 10-BM. At 10-5M them. e. p. p. s. disappeared with no change in end:-
plate membrane potential. The drug solut"ion was replaced by Krebs 
solution and them. e. p. p. s. returned at an increased amplitude and time 
course which did not completely return to control values after 150 min. In 
one experiment the m. e. p. p. frequency was greatly increased in the 
final rinse solution. (Table 5A). 
Effects of methoxyambenonium on (+)-tubocurarine e. p. p. s 
Methoxyambenonium, at a concentration of 10-8M, increased the 
amplitude of the e. p. p. s without change of time course. At 10-7M and 
10-6M both amplitude and time course were increased; 10-6M increased 
the amplitude by 219%, the rise-time by 114% and the half-decay by 211%. 
After 15-min perfusion with 10- 6M methoxyambenonium, the muscle began 
to twitch and the recording was lost. (Table 5B). 
Effects of acetylcholine 
In four experiments acetylcholine (ACh) produced no consistent 
TABLE 5A 
Effects of Methoxyambenonum on _M. e. p. p. s. 
Concentration Frequency ! I 
of of I Membrane 
methoxy- m. e. P·f· s Amplitude Rise-ti~e Half-deck.y potential 
ambenonium (M) (sec- )a (mV)b (msec) (msec)b (mV) 
Control 2. l+O. 3 0.7+0.l 0.6+0.l 1. o+o. 2 73 
10-8 2.7+0.4* 0.6+0.l o. 5+0. 1 1. o+o. 2 73 
10-7 2. l+O. 4 o. 8+0. 1 0.7+0.l 1. 5+0. 2** 71 
10-6 2.0+0.2 o. 6+0,l 0.7+0.l 1. 5+0.1** 73 
10-5 71 
For symbols see Table 2A. 
Concentration 
of 
methoxy-
ambenonium (M) 
Control 
10-8 
10-7 
10-6 
For symbols see Table 2A 
i 
TABLE 5B 
' 
I 
Effects of Methoxyamenonium on E. p. p. s. (3µg/ml Td) 
I 
Amplitude Rise-time Half-decay 
(mV)b '. (msec)b (msec)b 
3. l+O. 2 0.1+0.1 0.9+0.l 
3.6+0.2** 0.8+0.l 0.9+0.l 
6.6+0.4** 1. o+o. l** 1. 3+0. l** 
9.9+0.6** 1. 5+0. l** 2.8+0.l** 
Membrane 
potential 
(mV). 
66 
66 
68 
68 
bO 
changes in m. e. p. p. frequency, either as the concentration was increased 
during the sarv.e experiment or at the same concentration in different 
experiments. The frequency varied throughout the experiment and it is 
unlikely that any changes were drug-induced. ACh did not increase the 
amplitude or time course of the m. e. p. p. s, but at concentrations greater 
than I0- 4M, the amplitude diminished as the end-plate membrane was 
depolarized. (Table 6). 
Effects of tubocurarine 
Experiments using tubocurarine alone showed no significant changes 
of amplitude ur time course of e. p. p. s over a period of 2 hr. In 
experiments using 5-10 µg/ml tubocurarine, similar changes tO those 
recorded above were observed but higher concentrations of the facilitatory 
drugs were required. Concentrations of tubocurarine of 10-15 µg/ml 
completely prevented any increases in amplitude and time course in the 
presence of the facilitatory drugs. 
DISCUSSION 
.All the facilitatory drugs used produced statistically significant 
changes in m. e. p. p. frequency. However, the changes were small and 
assuming that a ten fold increase in frequency of the m. e. p. p. s repre-
Cone entration 
of 
acetyl-
choline (M) 
Control 
10-8 
10-7 
10-6 
10-5 
10-4 
10-3 
For symbols see Table 2A. 
TABLE 6 
Effects of Acetylcholine on M. e. p. p. s 
Frequency 
of 
m. e. p. p. s Amplitude Rise-t~e 
(sec-l)a 
. (mV)b (msec) 
1. 2+0. 2 0.8+0.2 0.6+0.l 
1. l+O. 1 0.9+0.2 o. 7+0. 1 
1. 3+0. 4 0.9+0.2 o. 7+0.1 
1. 5+0. 3* 0.8+0.2 o. 6+0. 1 
1. 5+0. l** o. 8+0. 1 0.6+0.2 
1. 5+0. 2** 0.7+0.l o. 6+0.1 
Half-decw 
(msec) 
1. o+o. 2 
I. o+o. 2 
0.9+0.2 
1. o+o. 2 
1. l+O. 1 
1. o+o. 2 
Membrane 
potential 
(mV) 
70 
71 
70 
71 
71 
70 
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sented a 15 mV depolarization of the nerve terminal (Liley, 1956b), 
depolarization of the terminal could only have been in the order of 1 to 3 
m V. Also, m. e. p. p. frequency varies over an extended period of time 
(Boyd and Martin, 1956a) thus some of the changes noted may have been 
spontaneous and not drug-induced. 
Boyd and Martin (19 56a) also. noted a change in m. e. p. p. frequency 
using 3. 3 X 10- 7M neostigmine and a decrease at 3. 3 X 10-6M, but as in 
the present results, the changes recorded were only small. The reduction 
of frequency at higher concentrations may simply reflect the difficulty 
in observing the m. e. p. p. s which were greatly decreased in amplitude 
when the end-plate was depolarized. No change in m. e". p. p. frequency 
has been observed in the frog sartorius using neostigmine (Fatt and Katz, 
1952) or iri the rat diaphragm using neostigmine (Liley, 1956a). 
It is difficult to assess the importance of the small changes in nerve 
terminal membrane potential that these increases in m. e. p. p. frequency 
reflect. The change in spontaneous release of ACh indicated by the 
change in m. e. p. p. frequency is probably not physiologically significant. 
However, this small e.ffect on the terminal may be indicative of a pre-
synaptic action which do.es have significant effects on the release of A Ch 
due to nerve action potentials. 
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The changes in time course of them. e. p. p. s were much more easily 
observed and more consistent than the changes in amplitude. Since the 
changes in a.~plitude were small_<:~?__o_n~y_()_':~ur:~:?_i1:_~~e p:r~s_ence of 
changes of time course, it can be concluded that the drugs produced no 
significant changes in the sensitivity of the end-plate. This conclusion 
confirms that of Blaber (1963), and the changes in end-plate sensitivity 
produce.cl by methoxyambenonium in frog muscle (Karczmar et al., 1961) 
point to a species difference in the effect of these drugs at the neuromus-
cular junction. A logarithmic plot of amplitude during the decay of the 
e. p. p. was found to be linear with time, both in the control recordings 
and in the presence of facilitatory drugs; thus an increase of the time to 
half-decay indicates prolongation of time course. The degree of prolon-
gation gives a rough estimate of the anticholinesterase activity of these 
compounds. Thus ambenonium is the most potent cholinesterase inhibitor, 
while neostigmine, methoxyambenonium and edrophonium exhibit decreas - ; 
ing potencies. Edrophonium produces no effects on m. e. p. p. amplitude 
or half-decay. This indicates that edrophonium does not inhibit cholin-
-6 
esterase up to a concentration of 10 M. Changes in amplitude and time 
course of m. e. p. p. s have been reported in other species previously, 
neostigmine (3. 3 X 10- 6M) in frog sartorius (Fatt and Katz, 1952}, neo-
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stigmine (3. 3 X 10-6M) in rat diaphragm (Liley l956a.) and also in the cat 
tenuissimus muscle,, neostigminefa. 3 X 10-7M) (Boyd and Martin, l956a). 
Edrophonium (lo-4M) and neostigmine (10- 5M) produced depolarization 
of the end-plate,, confirming the conclusions of Nastuk and Alexander 
{1954).. and Katz and Thesleff (1957). These concentrations are higher 
than those necessary to facilitate transmission and would indicate that 
depolarization of the end-plate is not a factor in the production of 
facilitation of neuromuscular transmission by these drugs .. confirming the 
conclusion of Blaber and Bowman (1959). 
Ambenonium (l0- 5M) and methoxyambenonium {lo- 5M) produced a 
decrease in the amplitude and time course of the m. e. p. p. s without 
any change in the resting potential of the e. p. membrane. These drugs 
have been shown previously to produce neu1·omuscular paralysis 
resembling that of {+)-tuobcurarine (Blaber, 1960). This potent curare-
like action may account for the unusual observation that methoxyam-
benonium increased the half-decay time but not the amplitude of the m. e. 
p. p. s. 
The facilitatory drugs also increased and prolonged the {+)-tubocura-
rine e. p. p. but the effects on e. p. p. s occurred at concentrations which hac 
I 
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no effect on the m. e. p. p. s. This fact, together with an increase in 
amplitude and no change in time-course of the . e. p. p. indicates a pre-
synaptic action .for these drugs. 
Masland and Wigton (1940) and Eccles (1964) have suggested that 
ACh may be mediating in the action of the facilitatory drugs on the motor 
nerve terminal after inhibition of cholinesterase. However, the present 
results show that the time course of the e. p. p. was not prolonged at the 
time it was augmented, showing cholinesterase was not inhibited. Also, 
A Ch was found not to produce any change in frequency of m. e. p. p. s, thus 
confirming the results of Hubbard, Schmidt and Yokota (1965). These 
results, although not eliminating A Ch as a mediator, would suggest that 
nerve terminal effects are not produced by a previous inhibition of 
cholinesterase, though the drugs may sensitize the nerve terminal to an 
action of ACh. The action of ACh would not be to depolarize the terminal, 
since no change in m. e. p. p. frequency was produced. 
Because the amplitude of the m. e. p. p. s was not increased in the 
absence of a prolonged time course, it can be assumed that the size of 
the quantum is not increased by facilitatory drugs. The increase in ACh 
release for each stimulus mu~t. therefore. be due to an increase in the 
quantal content of the e. p. p. 
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Further work is required to support the present conclusions since 
they are based upon the assumption that m. e. p. p. s and e. p. p. s di.ff er 
only in their mechanism of release. But m. e. p. p. s are well kr10wn for 
their small and highly variable amplitude (Fatt and Katz, 1952). E. p. p. s 
are comparatively large and very constant in amplitude. It is possible 
that the present results show no significant changes of the m·. e. p. p. s 
only because of this high variability. This can be illustrated by the 
results with methoxyambenonium (Table 5). 10-8M methoxyambenonium 
increased the e. p. p. amplitude by 16%. The same percentage increase 
of the m. e. p. p. amplitude (O. 7 to O. 8mv) would not have been significant. 
Thus the initial conclusion that the facilitatory drugs act by a pre-junc-
tional action is weakened and must be tested by further experiments. 
RESULTS SECTION 2 
EFFECTS OF FACILITATORY DRUGS ON 
(+)-TUBOCURARINE E. P. P. SAND IONTOPHORETIC 
ACETYLCHOLINE AND CARBACHOL POTENTIALS. 
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INTRODUCTION 
From the prev-ious experiments it was concluded that the e. p. p. 
amplitude-was augmented at a concentration of facilitatory drug which was 
approximately one-tenth the concentration necessary to produce an effect 
on m. e. p. p. amplitude or time-course. Since m. e. p. p. s have a high 
variability and low amplitude, further experiments were performed to 
provide additional information regarding the mechanism of action of the 
facilitatory drugs. Therefore experiments were performed with the 
same drugs, using a microelectrode drug application technique (Nastuk, 
1953a and Del Castillo and Katz, 1955a). This technique was used for the 
following reasons. First, the membrane potential change resulting 
from iontophoretic application of ACh is not as V8.riable as m. e. p. p. s. 
Second, the ACh-potential can be adjusted to any desired amplitude, simply 
by increasing the current which passes through the electrode. Finally. 
it is possible to record both the e. p. p. and ACh-potential at the same 
muscle. e. p., thereby eliminating any variability of drug response which 
may occur between different muscle fibers. 
RESULTS 
It proved to be quite difficult to maintain ACh-potentials at a 
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constant amplitude for long periods of time. Thus both ACh-potential 
amplitude and half-decay time were observed to ·determine the presence 
of drug-induced changes to the response of ACh at the e. p. membrane. 
-- ~-- ---·· ·- -
(The half-decay seemed very constant·for long periods of time, even 
though the amplitude decreased considerably.) 
Effects of the facilitatory drugs on (+)-tubocurarine e. p. p. s and A Ch-
potentials. 
Neostigmine. 
Table 7 shows the results obtained from two experiments with 
neostigmine. In EXP #1 neostigmine produced no signi~icant changes at 
10-8M, although there were ·small effects {less than 10%) on the ACh-
potential. At 10-7M there were large changes in both the e.p.p. and 
A Ch-potential. In EXP #2 the e. p. p. was augmented by 10-8M neostig-
mine. The increase was 28% of control and was highly significant. Also, 
the ACh-potential was prolonged by 17%, although this increase was not 
as significant as the effect on the e. p. p . 
.E_~drophonium. 
It was quite difficult to produce the e. p. p. changes at 10-7M edro-
phonium which had been observed in the prmous section. However, 
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TABLE 7 
Effects of Neostigmine on E. p. p. s 
, .. and ACh-potentials (4 µg/ml. Tc) 
· Concentration ·-·E. P. P. . --Ach -potential A Ch-potential 
of amplitude amplitude half ideca:b 
neostigmine (M) (mV)b (mV)b {msec) 
EXP #1 
Control 2.6+0.2 1. 4+0. 1 480+30 
10- 8M 2.5+0.1 1. 5+0. 2 520+30 
(0) (7%) -(8%) 
-7 
10 M 3.6+0.2** 3.3+0.2** 760+50*ii~ 
(38%) (i::j6%) (58%) 
EXP #2 
Control 1. 8+0. 1 I. 3+0. 1 120+10 
I0- 8M 2. 3+0. Iii~* I. 3+0. 1 140+10* 
(28%) (0) 0.7%) 
~~ Difference statistically significant at the 1 % level. 
** Difference statistically significant at the 0.1% level. 
b + Standard deviation. 
Values in parentheses indicate the percentage increa.se over control. 
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TABLE·a 
Effects of Edrophonium on E. p. p. s 
. and ACh-potentials (4 µg/mlTc} 
Concentration E. P. P. A Ch-potential ACh-potential 
of amplitu.ge amplitude half-decay 
edrophonium (M) (mV) . {mV)b {msec)b 
EXP #1 
Control I. o+o. 1 I. 9+0. I 110+10 
I0- 7M 1. l+O. 1 1. 5+0. I 110+10 
(10%) - (0) (0) 
EXP #2 
Control 1. 4+0. 1 1. 8+0. 3 280+10 
10- 6M 2.2+0.2** 2. 1+0. 2 350+20** 
(57%) (17o/o) (25%) 
EXP #3 
Control 1. 5+0. 2 1. 7+0. I 550+30 
10-BM 1. 4+0. 2 I. 4+0. I 500+60 
(O) (0) (O) 
I0-7M 1. 5+0. 2 1. 8+0. 1 620+60 
(O) (6%) (20%) 
10- 6M 2. o+o .. 2~~* 2. 7+0. 2::.;;* 710+40>:•* 
(33%) - (59%) (29%) 
For symbols see Table 7 
L-..------------------------...---...----------------------------..---~~"'""""'--d 
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there were large changes in both the e. p. p. and ACh-potential at 10- 6M 
edrophonium (Table 8). 
· Ambenonimn. 
The experiments with ambenonium resulted in almost identical 
increases in e. p. p. amplitude and ACh-potential half-decay (Table 8 and 
Figure 3). The only difference occurs in EXP #2 at io-9M ambenonium 
when the e. p. p. was augmented, significantly, by 16% while the ACh-
potential half-decay was increased by 8%. which was insignificant. 
Methoxyarnbenonium. 
EXP #1 shows large increases in e. p. p. amplitude and ACh-potential 
amplitude at 10- 8M methoxyambenonium. 10- 8M was much less effective 
in EXP #2, although the small increase of e. p. p. amplitude was sign: f-
'icant (Table 10). 
Time-course of anti-Tc action. 
In a series of four experiments effects of the facilitatory drugs were 
observed continuously from the beginning of drug infusion. In this way it 
was possible to determine if effects on e. p. p. amplitude followed the 
same time-course as effects on ACh-potential amplitude or half-decay . 
. The results of one experiment are illustrated in Figure 4, Records were 
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A 
-
-
Figure 3. The effect of ambenonium on e. p. p. s and ACh-potentials 
recorded in the presence of 4 µg/ml (+)-tubocurarine:A- -control e. p. p. 
and ACh-potential; B-~with 10-8M ambenonium. Voltage calibration, 5mV; 
time calibration, 100 msec; current, 2. 5 x 10- 7 amps. 
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TABLE 9 
Effects of Ambenonium on E. p. p. s 
• and ACh-potentials (4 µg/ml Tc) 
e oncentration --E. P. P. ACh-potential ACh-potential 
of amplitude ampli~de half-decay: 
ambenonium (M) (mV)b (mV) (msec)b 
EXP#l 
Control 1. 7+0. 1 2. ·4+0. 2 80+10 
10-9M 1. 7+0. 1 1. 4+0.1 90+10 
-(0) (O) (13%) 
-8 
10 M 3.0+0.2** 2.8+0.3 l40+10:\0 l: 
(76%) (17%) (75%) 
EXP #2 
Control 1. 9+0. 1 2.0+0.2 130+10 
l0- 9M 2. 2+0. l*:\( I. 9+0. 1 140+10 
06%) (O) (8%) 
10-8M 5. l+O. 5*:\( 2.2+0.1 350+10:\(:\C 
(l68%) 00%) (169%) 
For symbols see Table 7 
TABLE 10 95 
Effects of Methoxyambenonium on E. p. p. s 
and .AC:h-potentials (4 µg/ml Tc) 
, 
Concentration of E. P. P. AGh-potential AGh-potential 
methoxy- amplitude amplitude half-decal 
ambenonium (M) (mV)b (mV )b (msec) 
EXP #1 
Control 6.6+0.3 4. 2+0. 1 60+10 
10-BM 11. 4+0. 2*:>i'< 6.6+0.8** 50+10 
(73%) (57%) (0) 
EXP #2 
Control 2. 1-10. 1 I. 7+0. 1 140+10 
10-BM 2. 4-IO. J>:c I. 5+0. 1 150+10 
(14%) (0) (7%) 
10- 7M 3. 8+0. 3*>:c I. 2+0. I 180+10** 
(81%) (O) (29%) 
For syi.nbols see Table 7 
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Figure 4. The effect of ambenonium on e. p. p. (•) and ACh-potential (x). 
amplitude recorded in the presence of 4 µg/ml (+)-tubocurarine versus time: 
A1--beginning of 10-
8M ambenonium infusion; A2-- beginning of rn- 7M 
ambenonium infusion. 
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made every thirty seconds throughout the experiment. The controls were 
relatively constant. 10-SM ambenonium produced parallel increases in 
both e. p. p. amplitude and ACh-potential amplitude. Two minutes after 
-7 
-beginning-to -infuse 10 M ambenonium,- both-potentials.increased very 
rapidly in amplitude. 
Effects of the facilitatory drugs on (+)-tubocurarine e. p. p. s and 
carbachol-potentials. 
Non~ of the drugs studied (neostigmine, edrophonium, ambenonium 
and methoxyambenonium) produced changes in the carbachol-potential at 
doses which caused considerable augmentation of e. p. p. amplitude. This 
is illustrated in Figure 5. After control records, l0- 6IVJ methoxy·-
ambenonium was administered. The e. p. p. and carbachol-potential were 
recorded every thirty seconds. After three minutes of methoxyambenonium 
infusion there was a rapid augmentation of the e. p. p. amplitude, but no 
change in the carbachol-potential. After four minutes, the e. p. p. was not 
recorded to avoid any subsequent muscle twitches. Even after ten 
minutes there was no change in the carbachol-potential. 
DISCUSSION 
In five of seven experiments there was a statistically significant 
\' 
'ft 
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A 
-
l 
B . J.._ . L 
-
Figure 5. The effect of methoxyambenonium on e. p. p. s and carbachol-
potentials recorded in the presence of 4 µg/ml (+)-tubocurarine: A--control 
e. p. p. and carbachol-potential; B--with 10- 6M methoxyambenonium. _8 Voltage calib.1;~~tion, 5 m V; time calibration, 500 msec; current, 3. 2xl0 
amps. 
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increase in ACh-potential amplitude or half-decay at the same minimal 
concentration as the increase in e. p. p. amplitude. Two experiments in 
which there was no correlation (ambenonium EXP #2 and methoxyambenon-
ium EXP #2) showed small, but significant, increases in the e. p. p. ampli-
tude at concentrations which did not significantly affect the ACh-potential. 
Yet the changes of the A ch-potential are 50% as large as the changes in 
the e. p. p. at the low concentrations. In fact, in ambenonium EXP #2 
-8 10 M ambenonium produced exactly the same percentage changes (168% 
and 169%) in e. p. p. amplitude and ACh-potential half-decay. On the 
basis of these results it seems likely that there is a good correlation 
between the effects of facilitatory drugs on the e. p. p. and ACh-potential 
in a curarized mammalian neuromuscular preparation. 
This conclusion is substantiated even further by the observation that 
augmentation of the e. p. p. and ACh-potential amplitudes follow approxi-
mately the same time course, as shown in Figure 4. These conclusions 
are very similar to those of Goldsmith (1963) and Otsuka and Nonomura 
(1963). Both papers gave results showing the effects of edrophonium on 
e. p. p. s and ACh-potentials at the frog neuromuscular junction. 
Correlation between effects of facilit:i.tory drugs on e. p. p. s and 
A Ch-potentials can be explained by several postsynaptic mechanisms of 
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action. The most likely mechanism involves the cholinesterase inhibiting 
properties of the facilitatory drugs. This theory receives strong support 
from the observation that the action of a stable choline ester (carbachol) 
is not affected by facilitatory drugs. This would eliminate the other 
possibilities, sensitizing and depolarizing actions, which have been 
hypothesized (Riker and Wescoe, 1946 and Karczmar, 1957). · If sensitizing 
or depolarizing actions were occurring, an increase in the carbachol-
potential should have been observed. 
RESULTS SECTION 3 
EFFECTS OF FACILITATORY DRUGS ON 
QUANTAL CONTENT OF THEE. P. P. 
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INTRODUCTION 
Calcium ions are essential for transmitter release at the neuro-
muscular junction. By decreasing the calcium ion concentration or 
increasing the magnesium ion concentration in the Ringer solution, 
release of transmitter can be decreased to any level. At appropriate 
concentrations of calcium and magnesium the average quanta in a single 
e. p. p. is near one {equivalent to a m. e. p. p. ). At this level of blockade 
it is possible to quantify transmitter release per indirect stimulus (Del 
Castillo and Katz. 1954c). · 
The facilitatory drugs were tested in a deficient calcium preparation 
to determine if they were capable of increasing the quanta! content of 
the e. p. p .. 
RESULTS 
The effects of neostigmine. edrophonium, ambenonium and methoxy-
ambenonium are illustrated in Tables 11 to 14, respectively. The quanta! 
content was measured by two methods: 
and 
I) ave. e. p. p. amplitude of 50 samples 
ave. m. e. p. p. amplitude of 50 samples 
2) loge no. of e. p. p. s 
no. of failures 
in 200 trials (Figure 6). 
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Figure 6. Effect of edrophonium on quanta! release. Indirect stimulation 
at the artifact. (a) control; (b) with I0- 6M edrophonium. Voltage calibra-
tion, 1 m V; time calibration, 5 msec. 
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TABLE 11 
Effect of Neostigmine on Quanta! Content 
Quanta! Content 
Concentration Mg (10-15mM)a Ca (O. 92 mM) 
of Mg (5-? mM)b 
neostigmine (M) Muscle 1 Muscle 2 Muscle 3 Muscle 4 
Control 2.1 1. 9 0.54 o. 71 
-8 
10 2.1 2. 0 0.42 0.87 
10- 7 2.1 1. 9 0.68 0.70 
io- 6 1. 7 0.64 0.73 
10- 5 
. 1. 8 o. 82* 
Average amplitude of 50 e. p. p. s 
a - Average amplitude of 50 m. e. p. p. s 
b _ number of stimuli Log en·1mber of failures 
* indicates a significant increase of 33% or a significant decrease of 
25% (Edwards and Ikeda, 1962). 
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TABLE 12 
Effect of Edrophonium on Quantal Content 
Quantal Conte~_! 
Concentration Mg{l0-15 mM)a Ca (O. 92 mMb 
of Mg (5-7 mM) 
edrophonium (M) Muscle 1 Muscle 2 Muscle 3 Muscle 4 
Control 1. 2 2.4 0.36 o. 87 
10-8 I. 2 2. 5 0.45 0.96 
-7 
10 1. 2 2. 9 0.34 0.90 
10-6 1. 6* 2. 6 0.44 1. 4* 
10-5 2. 4 1. 3* 
For symbols see Table 11 
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TABLE 13 
Effect of Ambenonium on Quanta! Content 
Quanta! Content 
Concentration Mg (10-15 mM)a Ca (0. 92 mM) 
of Mg (5-7 · mM)b 
ambenonium (M) Muscle 1 Muscle 2 Muscle 3 Muscle 4 
Control 1. 6 1. 5 0.67 1. 9 
10-10 1. 8 1. 6 o. 81 1. 8 
10-9 1. 8 1. 7 0.66 1. 9 
10-8 1. 8 2. o* 0.53 1. 7 
10-7 2.0 2.2* 0. 33::!c 2. 0 
10-6 1. 8 1. 4 o.2s* 1. 7 
~ ""'-5 
10 1. 5 
For symbols see Table 11 
', 
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TABLE 14 
Effect of Methoxyambenonium on Quanta! Content 
Quanta! Content 
Concentration a Ca (O. 92 mMb Mg (10-15 mM) 
of methoxy- Mg (5-7 mM) 
ambenonium (M) Muscle 1 Muscle 2 Muscle 3 Muscle 4 
Control 2. 5 3. 6 0.79 1. 04 
-8 
10 2. 5 3. 6 o. 89 o. 83 
10-7 3.4* 3. 9 0.59 0.74* 
10-6 3. 2 0.92 o. 82 
For symbols see Table 11 
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With either of these techniques the facilitatory drugs did not produce 
consistent coonges in the quantal content of the e. p. p. at any concentration. 
DISCUSSION 
The quantal content of the e. p. p. in deficient calcium or increased 
magnesium ions is not increased significantly by facilitatory drugs. 
This is similar to the conclusion of Hubbard. Schmidt and Yokota (1965). 
except they observed a small decrease in quantal content of the e. p. p. 
in the presence of neostigmine. 
M. e. p. p. s and e. p. p. s in high magnesium or low calcium are 
augmented at.the same concentrations. Also. both are depressed at 
high concentrations. indicating the e. p. p. s and m. e. p. p. s are affected 
by the same postsynaptic mechanisms. 
Augmentation of the e. p. p. s and m. e. p. p. s is compatible with the 
theory of cholinesterase inhibition by facilitatory drugs. Depression at 
higher concentrations is probably due to direct competitive or depolarizing . 
actions. · 
Thus these results can be explained completely on the basis of 
postsynaptic actions and they indicate that in a calcium deficient solution 
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facilitatory drugs do not increase release of transmitter from pre-
synaptic nerve terminals. 
.. 
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RESULTS SECTION 4 
EFFECTS OF BENZOQUINONIUM 
AT THE NEUROMUSCULAR JUNCTION 
110 
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INTRODUCTION 
Benzoquinonium {Bz} produces competitive blockade of neuromuscular 
-transmission,,-and in this respect acts much like-(+)-tubocurarine. The 
distinguishing feature of benzoquinonium blockade is that it is not _antag-
onized by facilitatory drugs (Hoppe,, 1950; . Hougs and Johansen,, 1957; 
Bowman,, 1958 and Blaber and Bowman,, 1962}. As Blaber and Bowman 
(1963a and 1963b} concluded facilitatory drugs act at the motor nerve 
terminal, Blaber and Bowman {1962 and 1963a} further concluded that 
benzoquinonium prevents the action of facilitatory drugs at the motor 
nerve terminal. 
Alternatively,, it is possible that the potent anticholinesterase activity 
of benzoquinonium (Hoppe, 1951 and Blaber and Bowman,, 1962) prevents 
any subsequent inhibition of cholinesterase by facilitatory drugs. 
The following experiments attempt to elucidate the sites of action 
of benzoquinonium and thereby obtain presumptive evidence for the 
mechanism of action of facilitatory drugs. 
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RESULTS 
Benzoquinonium control 
- The e. p. p. recorded when the m~scle was blocked by Bz progres- · 
sively decreased in size as a function of time. This was especially evident· 
in the amplitude, which decreased by approximately 50% after one hour ~f 
recording (Figure 7). There were much s'maller decreases in rise-time 
and half-decay (Figure8). 
Effects of the facilitatory drugs on the benzoquinonium e. p. p. 
Infusion of concentrations of neostigmine, edrophonium, ambenonium, 
or methoxyambenonium which increased the amplitude and/ or time course 
of e. p. p. s recorded during Tc blockade, produced little change in the 
rise-time, half-decay, or amplitude of the Bz e. p. p. (Figure 9). There 
was a continuous decrease of the amplitude; but the rate of decline resem-1; 
bled closely that observed in the control e. p. p. with Bz alone. Since the 
drug concentrations were changed at 15 minute intervals, the slopes of 
Figure 7 and 9 can be compared. At high concentrations of the facili-
tatory drugs, effects on the e. p. p. were observed. Concentrations 
of 10-4M edrophonium caused a facilitation of all parameters. 10- 5M 
neostigmine increased the time to half-decay. Ambenonium prolonged the 
. -7 -6 -5 half-decay at concentrations of 10 M and 10 M. Also, 10 M amben-
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Figure 7. E. p. p. amplitude recorded in a muscle fiber blocked by Bz 
(2 µg/ml). Zero time represents the time at which an e. p. p. was located 
and the first record taken. 
.:-
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L 
Figure 8. End-plate potentials recorded in a muscle fiber blocked by Bz 
(1. 5 pg/ml). E. p. p. s recorded at 30 mins (upper trace}, 60 mins {center 
trace, 90 mins (lower trace) after beginning of the Bz infusion have been 
superimposed. Voltage calibration 5 m V; time calibration 1 msec. 
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Figure 9. The effects of facilitatory drugs on the amplitude of e. p. p. s 
recorded in a muscle blocked by Bz. C represents the control reading with 
Bz alone. The facilitatory drugs were added 15 min after the control 
reading and the concentrations increased at 15 min intervals. 
onium and methoxyambenonium depressed the amplitude and rise-time. 
Comparison of the benzoquinonium e. p. p. with the (+)-tubocurarine e. p. p. 
It was observed that the values for the rise-time and half-decay of the_ 
Bz e. p. p. were prolonged when compared to a Tc e. p. p. In three experi-
ments a muscle was initially blocked. with the lowest possible concentration 
of Tc. ,After a rapid e. p. p. was found (rise-time < 1 msec and half-
decay< 1. 5 msec), the Tc was removed by washing until the m. e. p. p. s 
became visible. Then the $ame end-plate was blocked with Bz. This 
gave the results in Figure 10. When e. p. p. s of the same amplitude were 
compared for any effect on time course, it was found that the rise-time 
and half-decay of the e. p. p. s in Bz were about twice the duration when 
compared to the rise-time and half-decay of the e. p. p. s in Tc. When the 
Bz was washed out and replaced by Tc, the time course returned to that 
of the Tc control level. Each change-over from Tc to Bz, or from Bz to 
Tc, took approximately one hour. If a facilitatory drug was added to 
Ringer solution of the final Tc e. p. p., the facilitating action of these 
agents was considerably less potent than in the control Tc e. p. p. This 
decreased potency is obvious in the increased latency of action for 
ambenonium. Normally, 10-7M ambenonium produced its anticurare 
action in about five minutes, but in the final Tc solution, the anticurare 
~ ~--c --------------~---------------------. f~.: , 
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Figure 10. Comparison of the time course of e. p. p. s recorded in a muscle 
fiber blocked by Tc (2 µg/ml) and Bz (1. 5 µg/ml). Voltage calibration 5 
m V; time calibration l msec. 
.. ·, 
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action of ambenonium was delayed to about 15 minutes. In addition, the 
augmented amplitude of the e. p. p. occurred without any increase in the 
rate of rise (~igure 11). An action of the facilitatory drugs increasing 
the rate of rise of the e. p. p. during Tc blockade has been previously 
reported (Kuperman and Okamoto, 1964). 
Effect of benzoquinonium on m. e. p. p. frequency and time course 
Bz had little effect on m. e. p. p. frequency. There was only a slight 
increase which occurred at 10-8M. There was no significant increase at 
-7 Concentrations of Bz up to 10 M produced no effect on the m. e. p. p. 
amplitude and time course. At 10-7M Bz, the amplitude of m. e. p. p. s 
was depressed without any change in the resting membrane potential, thus 
confirming that Bz does not produce any depolarization of the end-plate. 
At 10- 61\II the m. e. p. p. s were too small to measure accurately. These 
effects are illustrated in Table 15A. 
Effect of benzoquinonium on Tc e. p. p. s 
In three of four experiments Bz produced a facilitation of the Tc 
e. p. p. As shown in Table 15B, this effect occurred at 10-8M and 10- 7 M 
Bz. The response was very slow to develop and the level of facilitation 
-:;~~".~;.~~<~<~?'_l'}•f-«.~-:~"7"!'·,~--~·~~-~~; 
1· 
·i• 
I 
.i.!:: 
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Figure 11. Comparison of the effects of facilitatory drugs in a muscle fiber 
blocked by Tc before Bz (a) and after Bz(b). In a, A is a control e. p. p. re-
corded in a muscle blocked by 3 µg/ml Tc; B is an e. p. p. recorded when a 
concentration of 10- 6M edrophonium was added to the perfusion solution. 
Between a and b the Tc was removed and the muscle blocked with Bz (1. 5 
µg/ml). The Bz was then removed and the muscle re-infused with Tc. In b 
A is a control e. p. p. recorded in a muscle blocked by 3 µg/ml Tc; B is an 
e. p. p. recorded when a concentration of 10- 6M edrophonium was added to 
the perfusion solution, and C when .I0-5M edrophonium was added to the per 
fusibn solution. Voltage calibration 5 m V; time calibration 1 msec. 
TABLE 15A 
Effects of B·enzoquinonium on M. e. p. p. s 
Frequency 
Concentration of 
Amplitude of m. e. p. p. s Rise-time 
benzoquinonium (M) (sec-l)a (mV)b (msec)b 
Control 3.0+0.4 1. 4+0. 3 o. 7+0. 1 
10 
-10 3.0+0.7 1. 5+0. l o. 7+0. l 
10-9 3. l+O. 3 1. 5+0. 3 o. 8+0. l 
10- 8 3.7+0.5* 1. 4+0. 2 o. 7+0.1 
10-7 3.3+0.6 0.9+0.2** o. 7+0. 1 
10- 6 
* Diff erenc~ statistically significant at the 1 % level. 
** Difference statistic.ally significant at the 0. 1 % level. 
--- M. e. p. p. s too small to measure accurately. 
a + Standard error of the mean. 
b + Standard deviation. 
' Half-de~y 
(msec) 
1. 2+0. l 
1. 3+0. 2 
1. 3+0. 2 
1. 2+0. 1 
1. 2+0. l 
i 
'. 
· ·-·,,,,.·~=as~ ' ' '· ,. ':\"' ·1'.~,~~~~~~ . 
' ' 
.. 
Membrane 
potential 
(mV) 
62 
60 
60 
60 
60 
60 
. ...,., 
TABLE 15B 
Effects of Benzoquinonium on E.-p. p. s 
R.ecorded in the Presence of 4 µg/ml Tubocurarine 
Concentration Membrane 
of Amplitude Hise-time Half-decay potential 
benzoquinonium (M) (mV)b (msec)b (msec)b (mV) 
Control 5. l+O. 4 0.7+0.l 1. 3+0. 1 73 
10-10 5. l+O. 3 o. 8+0. 1 1, 4+0.1 75 
10- 9 4.9+0.3 o. 8+0.l 1. 4+0. 1 77 
10-8 5. 6+0. 4* 0.8+0.l 1. 3+0. 1 75 
10-7 7. o+o. 3>.'<* o. 9+0. l** 1. 4+0. 1 75 
10-6 Muscle began to twitch 
i 
·-
-
For symbols see table 15A . 
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varies greatly between muscles. At concentrations above 10 M:, the 
three muscles in which facilitation occurred began to twitch; in the other, 
the level of blockade was increased. Bz, therefore, appeared to have a 
weak facilitatory action which occurred at 10-SM and 10 - 7 M. However, 
Bz significantly depressed the amplitude of them. e. p. p. s at 10-7M; 
therefore, the weakness of the facHitatory action may have been due to 
the presence of both facilitatory and curare-like actions at this concenc.· 
tration. 
Effect of benzoquinonium on quantal release 
Bz, at concentrations which did not decrease the amplitude of the 
m. e. p. p. s and e. p. p. s, produced no significant effect ori the quantal 
release in the presence of a high magnesium ion concentration (12-15mM) 
(50 m. e. p. p. amplitude/ 50 e. p. p. amplitude) or in low calcium (O. 92 mM) 
and high magnesium (5-7 mM) concentrations, based on the number of 
failures in 200 stimuli (Table 16). At concentrations where the m. e. p. p. s 
and e. p. p. s were very small, due to the curare-like action of Bz, a just 
significant reduction in the quantal content was observed. 
~-----------------------------------------------------1-2_4 ____ ___ 
;.• 
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TABLE 16 
, 
Effect of Benzoquinonium on Quanta! Content 
Quanta! Content 
Concentration 
of benzo-
quinonium (M) 
Control 
10-10 
10-9 
-8 
10 
10-7 
a 
-Mg (10-15 mM) 
Muscle 1 Muf?cle 2 
1. 6 2.3 
1.4 2.5 
1. 7 1. 9 
Average amplitude of 50 e. p. p. s 
a Average amplitude of 50 m. e. p. p. s 
number of stimuli 
b Loge number of failures 
Ca (0. 92 m~ 
Mg (5-7 mM) 
Muscle 3 Muscle 4 
o. 7 1. 2 
o. 6 I. 4: 
0.5* 1. 1 
0.4* 1. 4 
0.7* 
* Indicates a significant decrease (25% or more; Edwards and Ikeda, 1962). 
~---------------------, 
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DISCUSSION 
The potency of Bz in blocking neuromuscular transmission in the 
isolated tenuissimus of the cat is approximately twice that of Tc, agreeing 
· with the potency reported by Bowman il958) for ·the anterior tibialis 
muscle of the cat in vivo. 
The e. p. p. observed during Bz paralysis had a longer time course 
than that observed during Tc paralysis; the rise-time and half-decay being 
approximately double. These effects can be explained on the basis of 
cholinesterase inhibition by Bz. At the concentration used to block the 
muscle, 2. 4 - 4. 8 x 10-6M, cholinesterase would be inhibited approximately 
70-90% {Blaber and Bowman, 1962). The e. p. p. in the presence of Bz 
decreased in amplitude as a function of time. The reason for this failure 
to reach an equilibrium may have been due to a progressive decrease in 
quantal content, however, the reduction in quantal content was only 
observed at concentrations of Bz which reduced the amplitude of the e. p. p. s 
and, therefore, the accuracy with which the number of failures could be 
counted was also reduced. Quantal release at the concentrations of Bz 
used for blockade could not be measured by the techniques used. 
Facilitatory drugs, at concentrations which increase the amplitude 
of e. p. p. s in the presence of Tc produced no effect on the e. p. p. s in the 
presence of Bz, thus confirming the lack of effect of facilitatory drugs 
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in antagonizing Bz paralysis (Hoppe, 1950; Randall, 1951; Bowman, 1958; 
Blaber and Bowman, 1962). 
Ambenonium (10- 7M) produced a prolongation of the time course of the 
Bz e. p. p. thus showing the possibility of the further inhibition of cholin--
esterase in the presence of Bz. Bowman {1958) showed that TEPP would 
produce a small amount of ·antagonism against Bz; ambenonium is also a 
powerful cholinesterase inhibitor (Blaber, 1960) comparable in potency to 
TEPP. 10- 5M ambenonium and methoxyambenonium produced depression 
of the e. p. p., and high concentrations of these two drugs have been shown 
to have a curare-like action (Blaber, 1960). 
Neostigmine at 10- 5M increased the time to half-decay, and slowed 
the rate of decline in the amplitude of the Bz e. p. p. s. Edrophonium at 
a concentration of l0- 4M increased the amplitude and time course of the 
Bz e. p. p. At these concentrations edrophonium and neostigmine 
depolarize the end-plate and also antagonize the bfocking action of Bz in 
vivo in the cat (Blaber and Bowman, 1959). The depolarizing action 
produced at high concentrations of edrophonium and neostigmine is not 
thought to contribute to the facilitatory a.ction (Nastuk and Alexander, 1954; 
Katz and Thesleff, 1957a; Blaber, 1963). Thus it must be concluded that the 
facilitatory action of the drugs has ·been prevented by Bz. 
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_Bz (lo-SM) increased the amplitude of the Tc e. p. p. without any 
significant change in the time course, also there was no· effect on the 
m. e. p. p. s at this concentration. No increase in quanta! release has been 
- shown for-Bz bythe-·techniques···used-in.--the ·p-resent study. In this respect, 
it resembles the facilitatory drugs used in this study which produced 
similar effects. At 10-7M , Bz also prolongs the rise-time of the Tc 
e. p. p. Higher concentrations of Bz produced only depression of the Tc. 
e. p. p. due to its curare-like effect. Bz has been previously shown to 
antagonize the paralysis due to Tc in vivo in soleus and tibialis anterior 
muscles (Hougs and Johansen, 1958). 
Most of the effects of benzoquinonium can be explained on the basis 
of its ability to inhibit junctional cholinesterase. Thus benzoquinonium 
inhibits cholinesterase as it produces competitive blockade of the muscle. 
This cholinesterase inhibition accounts for the slight augmentation by 
benzoquinonium of the (+)-tubocurarine e. p. p. Also the facilitatory drugs 
are not able to augment the benzoquinonium e. p. p. except at concentrations 
which produce higher levels of cholinesterase inhibition (e.g. ambenonium) 
or produce direct, depolarizing actions (e.g. edrophonium and neostigmine) 
Although most of the evidence supports the theory of cholinesterase 
inhibition, this theory is not supported by the experiment illustrated in 
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Figure 11. Edrophonium was not able to antagonize (+)-tubocurarine after 
previous administration of benzoquinonium. This is similar to the 
'. ability of (+)-tubocurarine to decrease a drug-induced prolongation of an 
e. p. p. (Karczmar, Koketsu and Soeda, 1968). This prolongation is 
generally considered to be due to cholinesterase inhibition. Yet it is 
decreased by tubocurarine, even ·though tubocurarine has no· effect on 
cholinesterase inhibition, in vitro (Eccles, Katz and Kuffler, 1942 and 
Mcintyre and King, 1943). This may be explained somewhat by the fact 
that (+)-tubocurarine is capable of slightly decreasing the half-decay of a 
normal e. p. p. (Beranek and Vyskocil, 1968). 
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GENERAL DISCUSSION 
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The experimental results indicate that facilitatory drugs have 
several actions at the mammalian neuromuscular junction. Some of these 
results implicate a presynaptic mechanism of drug action for facilitatory 
drugs. The (+)-tubocurarine e. p. p. amplitude is augmented at a con-
centration which has no statistically significant effect on m. e. p. p. s. This 
is illustrated in Table 17. E. p. p. amplitude is augmented at 1/10 the 
concentration necessary to affect m. e. p. p. amplitude or time-course. 
Furthermore drug-induced changes in m. e. p. p. s, when they occur, are 
much smaller than drug-induced changes in e. p. p. s. This differential 
effect of facilitatory drugs on m. e·. p. p. s and e. p. p. s suggests that 
facilitatory c:trugs have a presynaptic mechanism of action. 1'his con-
clusion is based on the assumption that m. e. p. p. s and e. p. p. s are 
identical with exception that m. e. p. p. s do not require a nerv-e stimulus 
for release. This is not completely valid, as there are several 
limitations in the technique. 
1) M. e. p. p. s and e. p. p. s were recorded in different experiments. 
2) M. e. p. p. s were recorded in normal Ringers solution but e. p. p. s 
were recorded in the presence of (+)-tubocurarine. 
3) The amplitude of m. e. p. p. s averaged less than one m V while 
e. p. p. s averaged more than three m V. 
4) M. e. p. p. s involved one quantum of transmitter while e. p. p. s 
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TABLE 17 
, 
Minimal Molar Concentration of Drugs Producing 
;.,._ __ . 
Significant Changes in M. e~ p. p. s and E. p. p. s 
M. e. p. p. E~ p. p. 
Amplitude Half-decay Amplitude Half-decay 
Neostigmine 10-
7 10-7 10- 8 10- 7 
Edrophonium 10-7 10- 6 
Ambenonium 10-8 10- 8 10-10 10-8 
Methoxyambenonium 10-7 10-8 10-7 
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involved more than one-hundred quanta. 
5) M. e. p. p. s were more variable in amplitude and time-course 
than e. p. p. s. 
These considerations, especially the greater variability of m. e. p. p. s, 
make it questionable whether the effects summarized in TJ.ble 17 are 
attributable to a presynaptic action of the facilitatory drugs. It is possible 
that these results are due to a general technical inability to detect small 
changes in m. e. p. p. amplitude or time-course. 
These complications are overcome by the method of iontophoretic 
application of ACh to the e~ p. However, this method also has limitations. 
1) Iontophoretic applications of ACh are not physiological. They may 
not be acting at the same receptors and do not exhibit the same 
time-course of receptor activation as the normal release of ACh. 
2) Prolonged application of ACh may affect neuromuscular trans-
mission. 
3) The A Ch-potentials are not always stable for the duration of an 
experiment. 
Facilitatory drugs produce much larger changes in ACh-potentials 
than in m. e. p. p. s; thus the ACh-potentials seem more responsive tothe 
&...-..--...... ----------------__,~------------------------------------------..... 
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effeds of facilitatory drugs than the m. e. p. p. s. At high drug concen-
trations there are no significant differences between the magnitude of 
l augmentation of (+)-tubocurarine e. p. p. s and the magnitude of augmen-
f-~,. tation of ACh-potentials. On the basis of this observation it would appear 
that most of the changes of the e. p. p. which are induced by facilitatory 
drugs can be explained on the basis of postsynaptic actions. In order to 
explain all the changes observed with facilitatory drugs on the basis of 
postsynaptic actions it is necessary to show augmentation of the ACh-
potential and (+)-tubocurarine e. p. p. at the same minimal concentration of 
facilitatory drug. These results are summarized in Tuble 18. There is 
very good correlation between minimal concentrations 9f drug necessary 
to augment (+)-tubocurarine· e. p. p. s and ACh-potentials. There is a 
discrepancy in the results of the iontophoretic studies. The minimal drug 
concentrations necessary to augment (+)-tubocurarine e. p. p. s in ion-
tophoretic studies are consistently higher than minimal concentrations 
necessary to augment (+)-tubocurarine e. p. p. s in m. e. p. p. -e. p. p. 
studies. At these higher concentrations facilitatory drugs are also 
capable of prolonging m. e. p. p. s. The only difference in experimental 
technique is the presence of an ACh-electrode in the iontophoretic studies. 
Thus this electrode must be depressing the effects of facilitatory drugs. 
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TABLE 18 
Minimal Molar Concentration of Drugs Producing 
·- ·-·-Significant Changes in E. p~p. s and :A-Ch-Potentials 
E. P. P. ACH-POTENTIAL 
10-7 -7 Neostigmine Exp #1· 10 
Exp #' 2 10-8 10-8 
Edrophonium Exp # 1 10-6 · 10-6 
Exp # 2 
Ambenonium Exp # 1 10-8 10-8 
-9 -8 
Exp # 2 10 10 
-8 10-8 Methoxyamb enonium Exp # 1 10 
Exp # 2 10-8 10-7 
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There are several possible explanations for this depressant effect. 
1) A depressant action of A Ch at the neuromuscular junction~ 
ACh depolarizes the motor nerve terminal (Hubbard and Yokota, 
1964 and Hubbard. Schmidt and Yokota, 1965), and this action 
may depress the presynaptic actions of facilitatory drugs in 
iontophoretic experiments. 
2) Damage to the nerve terminal. 
Placement of an ACh-electrode involves considerable manipu-
lation. Such movement may damage the terminal such that it 
does not respond normally to pharmacological tests. 
· 3) Use of low amplitude e. p. p. s. 
Facilit~tory drugs are relatively ineff eclive in augmenting low 
amplitude e. p. p. s in the presence of high concentrations of 
(+)-tubocurarine. This is generally explained by a second action 
of (+)-tubocurarine, but it is possible that the facilitatory drugs 
are just not as effective in augmenting low amplitude e. p. p. s 
as high amplitude e. p. p. s. 
It is difficult to determine which of the above effects is responsible for a 
lack of drug action in the iontophoretic experiments. As the ACh-elec-
trocle had little effect on e. p. p. amplitude, it is unlikely that nerve termina 
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damage can explain these results. Any damage which would decrease the 
pharmacological effectiveness of a drug should also decrease physiological 
_rel.ease of transmitte~ •.. Any_d.epola_:r:Jzatio11 ol_a._n_erve tt;?r:i:ninal b_y A Ch 
would also be expected to decrease physiological release; although ACh 
may depress actions of facilitatory drugs by another mechanism. 
In spite of this discrepancy high concentrations of facilitatory drugs 
are very effective in augmenting .or prolonging A Ch-potentials. In fact 
the ability of facilitatory drugs to affect ACh-potentials is nearly equiva-
lent to their ability to affect e. p. p. s. On the basis of this observation it 
is necessary to conclude that most of the anti-Tc action of. facilitatory 
drugs on isolated curarized mammalian muscle preparations is due to 
postsynaptic actions. To determine conclusively that there is not a small 
presynaptic action by these drugs in the presence of (+)-tubocurarine, it 
would be necessary to augment e. p. p. s and A Ch-potentials at lower con-
centrations in iontophoretic studies. 
Low concentrations of a facilitatory drug produce an increase in the 
rate of rise of (+)-tubocurarine e. p. p. s without prolongation of time to 
half-dE'.cay. This effect can be explained by increased release of trans-
mitter, sensitization of the e. p. to the transmitter or possibly, depolari-
zation of the e. p. by facilitatory drugs (Otsuka and Endo, 1960b). It is 
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unlikely that facilitatory drugs have sensitizing or depolarizing actions, 
as these drugs are not capable of augmenting carbachol-potentials. This 
appears to leave only a presynaptic mechanism. 
~· It is generally assumed that cholinesterase inhibition will augment and 
~-
prolong the e. p. p. with no c~ange in the rate of rise. ~et in _several 
experiments facilitatory drugs did increase the rate of rise of ACh-poten-
tials without prolongation. Although not reported as such, the records of 
Katz and Thesleff (1957a) especially figure 1 -..,. give similar results with 
edrophonium in frog muscle. This increase in ACh-potential amplitude 
with no prolongation indicates that cholinesterase affects only the quantity 
of ACh reaching the e. p. In other words cholinesterase inhibition, espe- · 
cially low levels of inhibition, produces no prolongation of ACh action. 
Diffusion must be the major mechanism of termination of the action of 
iontophoretic ACh. It is difficult to determine if the same mechanism holds 
true for the involvement of cholinesterase in the generation of the e. p. p. 
It has been hypothesized that diffusion is quite important in the decay of 
transmitter action (Ogston, 1955), but it is unknown how important 
cholinesterase is in determining the initial quantity of transmitter reaching. 
the e. p. This observation on the effects of facilitatory drugs does not 
support the idea that cholinesterase inhibition can not increase the rate of 
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rise of (+)-tubocurarine e. p. p..s. This increase in the rate of rise j.s most 
prominent at concentrations of facilitatory drug, that do not prolong the 
e. p. p. At higher drug concentrations there is prolongation of the e. p. p •• 
indicating that cholinesterase inhibition does lengthen the action of the 
neuromuscular transmitter. 
The primary effect of facilitatory drugs on (+)-tubocurarine e. p. p. s 
in isolated mammalian muscle is cholinesterase inhibition. This conclu-
sion is supported by studies on quantal content.. None of the drugs tested 
produce increases in the quanta! release of the e. p. p. at concentrations 
whid1 produce large increases in (+)-tu.bocurarine e. p. p. s. Thus changes 
in amplitude of e. p. p. s in a high magnesium ion concentration parallel 
changes in amplitude of m. e. p. p. s. This result indicates a mechanism 
of action for the facilitatory drugs which is postsynaptic, and this .action 
may well be cholinesterase inhibition. 
Benzoquinonium blocks neuromuscular transmission much like 
(+)-tubocurarine, but blockade by benzoquinonium is not antagonized by 
facilitatory drugs (Bowman, 1958). As benzoquinonium e. p. p. s are 
prolonged (compared to (+)-tubocurarine e. p. p. s). it is likely that 
cholinesterase is at least partially inhibited by benzoquinonium. In vitro 
~·; ' 
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results indicate that benzoquinonium is nearly as potent as neostigmine 
in inhibiting cholinesterase {Blaber and Bowman, 1962). This inhibitio~ 
may explain the ability of benzoquinonium to augment the (+)-tubocurarine 
e. p. p. amplitude. Also, previous inhibition of cholinesterase by benzo-
quinonium limits the in..'1ibition of cholinesterase produced by the facilita-
tory drugs. 
The theory of cholinesterase inhibition by facilitatory drugs is support-• 
ed by experiments on neuromuscular depression produced by paired stimuli 
to isolated curarized frog muscle preparations. Neuromuscular depression 
··, .. 
is not affected by edrophonium or physostigmine (Takeuchi, 1958a; Otsuka, 
Endo and Nonomura, 1962 and Otsuka and Nonomura, 1963). If the facili-
tatory drugs increase the release of transmitter. they should increase the 
depletion-induced depression resulting from paired stimuli. Although 
this work was performed in frogs it is probably applicable to mammalian 
preparations. 
Although cholinesterase inhibition appears to be the primary action 
of facilitatory drugs on e. p. p. s, this action does not explain the sponta -
neous twitching observed in the presence of ambenonium. Originally, it 
was thought that m. e. p. p. s are augmented to such an extent by facilitatory 
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drugs that they give rise to propagated muscle action potentials. But Katz 
and Thesleff (1957b) concluded that even in small muscle fibers, cholin- · 
, esterase inhibition could not augment m. e. p. p. s sufficiently to induce 
muscle action potentials. It is possible that spontaneous twitching is due to 
spontaneous giant potentials (Liley, 1957). except giant potentials have been 
observed only in the rat diaphz:agm. Furthermore if they can give rise to 
fibrillations, they can not cause fasciculations. Fasciculations must be 
induced by motor unit a~tivity. 
A possible origin of drug-induced fasciculations is suggested by the 
experiments of Hubbard, Schmidt and Yokota (1965). Neostigmine ·(3. 3 x 
10-6M) reduces the stimulus threshold of a nerve terminal in the presence 
of (+)-tubocurarine or excess magnesium and decreased calciµm.Ringers. 
This apparent depolarization may initiate propagated activity in the motor 
nerve, which could spread throughout the motor unit giving rise to a 
fasciculation and antidromic activity (Masland and Wigton, 1940). 
Neostigrnine, edrophonium and ambenonium initiate spontaneous 
fasciculations and spontaneous antidromic nerve action potentials in vivo 
(Blaber and Goode, 1968). As neostigmine and edrophonium do not 
produce spontaneous twitching in isolated muscle, it is likely that in vitro 
preparations are not as responsive to facilitatory drugs as in vivo 
preparations. 
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Methoxyambenonium is as potent as neostigmine and edrophonium in 
augmenting the (+)-·tubocurarine e. p. p., but is unable to facilitate an 
indirect, maximal twitch (Blaber, 1960). If the sole mechanism of action 
_ .. ...of facilitatory drugs is cholinesterase inhibition, methoxyambenonium 
should al so produce facilitation of the maximal twitch. Blaber and Goode 
(1968) observed that methoxyambenonium is incapable of initiating. 
spontaneous antidromic nerve activity. Initiation of spontaneous activity 
may involve the same mechanism of action as facilitation of transmission. 
If this is the case, methoxyambenonium would not be expected to facilitate 
the muscle twitch. 
Repetitive muscle activity after an orthodromic stimulus lasts for c::. 
period of approximately 50 msec in the presence of a facilitatory drug 
(Blaber and Bowman, 1963a). The longest (+)-tubocurarine e. p. p. observed 
in the presence of high concentrations of a facilitatory drug, has a 
half fall of only 2. 8 msec. This degree of prolongation would not giv·e 
rise to prolonged repetitive muscle activity. It is necessary to assume 
that (+)-tubocurarine drastically decreases the prolongation induced by 
the facilitatory drugs (Eccles, Katz and Kuffler, 1942 and Karczmar, 
Koketsu and Soeda, 1968). Only in the presence of a deficient sodium ion 
concentration do facilitatory drugs pro long e. p. p. s to such an extent 
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(Fatt arid Katz, 1951 and Kordas, 1968). This discrepancy between e. p. p. 
half-decay time and length of repetitive activity suggests that a mechanism 
other than cholinesterase inhibition is involved in facilitation. 
;---
The occurrence of spontaneous twitching makes it seem likely that a 
pre synaptic mechanism is involved in the action of facilitatory drugs. The 
explanation, as to why it does not occur in the e. p. p. studies, may be 
involved in the depressant action of tubocurarine on the motor nerve 
terrninal. Small doses of tubocurarine depress the supernormal period 
of the nerve terminal spike (Hubbard and Schmidt, 1961 and Hubbard, 
Schmidt and Yokota, 1965) and drug-induced antidromic nerve activity 
(Werner, 1961; Blaber and Bowman, 1963b and Standaert, 1964). As the 
concentration of (+)-tubocurarine used in these experiments was well over 
the concentration necessary to produce 100% block of the muscle twitch, it 
is quite possible that the nerve terminal action of facilitatory drugs was 
completely depressed in these experiments. 
Defici_ent calciurn ions and benzoquinonium ;:ire even n1ore effective 
in blocking the terminal act ions of facilitatory drugs. For this reason a 
terminal effect would not be expected to occur in their presence either 
(Hubbard, Schmfdt and Yokota, 1965 and Blaber and Bowman, 1963a:). 
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This depressant effect of blocking drugs may be amplified by the abnormal 
environment of the isolated muscle. 
THEORY OF THE MECHANISM OF DRUG-INDUCED FACILITATION AND 
ANTI-Tc ACTION AT THE SKELETAL NEUROMUSCULAR JUNCTION 
The mechanisms of drug-induced facilitation and anti-Tc action by 
facilitatory drugs are at present in hypothetical stages. All facilitatory 
drugs appear to act at at least three sites: 
1) cholinesterase, 
2) directly at the e. p. , and 
3) presynaptically. 
The relative importance of each site of action depends on the particular 
drug being considered. 
· - - The presynaptic action of neostigmine, ed·rophonium, ambenonium and 
rr1ethoxyambenonium has not been clearly elucidated. It does not involve 
depolarization of the motor nerve terminal in the same manner as 
potassium ions. Yet neostigmine, edrophonium and ambenonium do depo-
larize the terminal at another site, possibly the first node, as hypothesized 
by Hubbard, Schmidt and Yokota (1965) and Blaber and Goode (1968). This 
..-------------------------------------------------v_.. ____________ ....., ______ ..,., 
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initiates spontaneous twitching. Methoxyambenonium blocks at this site, 
thus it is not capable of inducing spontaneous antidromic activity. · This is 
probably a direct action (not mediated by ACh)(Hubbard, 1965) as ACh did 
not produce spontaneous twitching. Also edrophonium and neostigmine 
should have produced spontaneous twitching at some concentration if the 
effect was due to ACh accumulation. 
Neo$tigmine increases the duration of the nerve terminal action 
potential and negative after potential (Hubbard and Schmidt, 1961 and 
Hubbard, Schmidt and Yokota, 1965). A longer duration of the terminal 
action potential should lead to increased release of transmitter. The 
prolonged negative afterpotential may also increase release somei..~hat; 
although according to Liley's theory (1956c), this release would be 
insignificant. To hypothesize that an augmented negative afterpotential 
increases the release of transmitter, it is necessary to hypothesize that an 
additional factor is involved (maybe calcium is accumulated, 
intraterminally). 
The augmented negative afterpotential probably generates antidromic 
nerve activity. This antidromic activity passes into the ventral root where 
it is recorded. Also, when it reaches a nerve terminal branch, it may 
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pass orthodromically into another terminal. This reverberation could 
lead to a continuous release of transmitter. 
, . 
In addition to a presynaptic action, facilitatory drugs inhibit junctional 
cholinesterase. _It is .ctifficJlll.to as_se_ss'Jhe r:o1e_Qf.cb_olineste.rase 
inhibition in facilitation. Yet this appears to be the primary mechanism 
involved in antagonism of high concentrations of (+)-tubocurarine. 
The direct actions of facilitatory drugs have only a very minor role in 
facilitation and antagonism of (+)-tubocurarine but they may be responsible 
for blockade of neuromuscular transmission at high concentrations. 
These same mechanisms probably are involved in the action of every 
drug.at the neu.r.omus cular junction. The importance of each action is 
determined by the chemical structure of the drug being studied. 
Depolarizing drugs act primarily by a direct, depolarizing action, but they 
also act at the nerve terminal and inhibit cholinesterase. Competitive 
blockers have a potent competitive blocking action, but may act at the 
terminal and inhibit cholinesterase (e.g. benzoquinonium). TEA and 
guanidine act primarily at the nerve terminal, but also exhibit direct 
actions. Thus the effect of a drug depends not on any one site of action 
but upon the sum of actions at many sites. 
·•. 
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SUMMARY 
1) The facilitatory drugs (neostigmine, edrophonium, ambenonium and 
methoxyambenonium) produced only small changes in m. e. p. p. 
frequency. As this effect was small compared to the effect of potassium 
ions, it was concluded that the facilitatory drugs did not significantly 
change the nerve terminal membrane potential. 
2) In all experiments in which no blocking drugs were present ambenonium 
produced spontaneous twitching. 
3) Each of the facilitatory drugs augmented but did not prolong the Tc 
e. p. p. Furthermore this augmentation of c. p. p. amplitude occurred ai 
low concentrations of facilitatory drug which had no effect on m. e. p. p. 
amplitude or time-course. This lack of correlation implicated a 
presynaptic site of drug action. 
4) When A Ch-potentials and Tc e. p. p. s were recorded, simultaneously; 
both were augmented by the same minimal concentration of facilitatory 
drug. However, the concentration of drug necessary to augment the Tc 
e. p. p. was higher when A Ch was applied to the e. p. by iontophoresis 
than in the experiments summarized in 3) above. 
5) The facilitatory drugs did not augment the carbachol-potential at any 
concentration. 
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6) The facilitatory drugs did not increase the quantal content of -the 
e. p. p. recorded in the presence of a low ·calcium ion and high magnesium 
ion concentrations. 
7) Benzoquinonium administration, unlike Tc, caused a continuous 
decline in e. p. p. amplitude. The benzoquinonium e. p. p. had a longer 
half-decay time, which is indicative of its ability to inhibit junctional 
cholinesterase. The facilitatory drugs were ineffective in augmenting 
the benzoquinonium e. p. p. 
8) The correlation between the :minimal concentrations necessary to 
augment the Tc e. p.p. and ACh-potential indicates that most of the 
effects of the facilitatory drugs in antagonizing Tc are due to a 
postsynaptic action. This postsynaptic action is probably cholinesterase 
inhibition, as the facilitatory drugs had no effect on the carbachol 
potential. The lack of correlation between effects on m. e. p. p. s and Tc 
e. p. p. s indicates that these drugs might have a weak presynaptic action 
in the antagonism of Tc. 
9) The conclusion that the primary effect of the facilitatory drugs is 
due to cholinesterase inhibition is supported by the lack 0f effect of 
these drugs on quantal release. Also most of the actions of benzo-
quinonium can be explained by it cholinesterase inhibiting properties. 
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10) Cholinesterase inhibition can not account for the production o.f 
spontaneous twitching by ambenonium. Thus a presynaptic effect must 
occur in the absence of Tc. 
li) On the basis of these results it seems that a presynaptic action of 
the fa~ilitatory drugs is minimal in the presence of high concentrations 
of Tc which are necessary for use of microelectrode recording 
techniques. 
,,. .. 
r' .-...----------------------------------
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